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ABSTRACT

GLYCAN CHARACTERIZATIONS WITH APPLICATION IN METAL ION
BINDING, THE 1918 INFLUENZA VIRUS NEURAMINIDASE FORMATION AND
HUMAN RECEPTORS
By
Hui Zhou
University of New Hampshire, September 2009
The EP glycoprotein, the major protein component isolated from the EP
fluid of the mollusc, Mytilus edulis, is known to bind many metal ions and to
contain 14.3% of carbohydrate in weight. To structurally evaluate the sugar
function of this glycoprotein, a new mass spectrometry-based strategy was
applied with a focus on the comprehensive characterization of its A/-glycans. This
included: a) accurate mass measurement and GC/MS to determine the
monosaccharide compositions; b) positive ion CID-MSn to disassemble the
deuterated permethylated derivates (CD3) to reveal the antenna sequence, and
natural methoxyl group location; c) negative ion CID-MSn on native glycans to
define general antennary topology. Three major complex-type A/-glycans were
characterized with two of them expressing an unique tetrasaccharides antenna
sequence: 4-0-methyl-GlcA(1-4)[GlcNAc(1-3)] Fuc(1-4)GlcNAc. The third one is
identified as a pentasaccharide antenna: mono-Omethyl-Fuc(1-2)-4-0-methylGlcA(1-4)[GlcNAc(1-3)]Fuc(1-4)GlcNAc. This is the first report of these novel Nglycans and their intriguing structures may implicate their involvement in metal
ion binding.

xi

The neuraminidase (NA) of the1918 influenza virus (H1N1) has active
(tetramer) and inactive forms (monomer/dimer) with difference residing in their Nglycosylations. A structural analysis was carried out on the released A/-glycans
from both tetramer and dimer forms. Significant amounts of fucosylated A/-linked
structures were detected in dimer compared to tetramer (relative ratio: 73.6% vs.
18.1 %), while no other structural difference were observed. Thus, it appeared
that fucosylated glycans can play a key role to inhibit the formation of the
tetramer NA, especially those located in the stalk region. However, enzymatically
incorporation of fucose onto the tetramer in vitro didn't alter its enzyme activity,
indicating that this regulation must occur at an early biosynthetic stage.
Common lectin methods failed to detect any Siala(2,3)Gal residues, the
proposed avian influenza virus receptors, in the human upper respiratory tract,
contrasting current reports that avian viruses can grow efficiently in the human
upper respiratory tract tissues. To solve this disparity, two mass spectrometrybased strategies were employed to identify the Sial-Gal linkages on two human
cell lines: Detroit 562 and A549, which represent the human upper and lower
respiratory tract, respectively. One strategy involved MSn fragment ion spectral
comparison with standard oligosaccharides. A second approach was to
differentiate sial-Gal with a specific cyclization reagent DMTMM. Using this
reagent, Sialetr(2,3)Gal epitope formed a lactone while Siala(2,6)Gal analog
provided a methyl ester, easily distinguished by a 32 Da mass difference.
Significant amounts of Siala(2,3)Gal were found in Detroit 562 cell lines,
confirming the presence of avian virus receptors in the human upper respiratory

xii

tract. Thus, the poor human-to-human transmission of avian influenza virus must
be attributed to other unknown reasons, rather than the paucity of SA(o2,3)Gal.
This is the first approach to identify influenza virus human receptors by mass
spectrometry.

xm

CHAPTER 1
Introduction to Glycosylation

1.1 Significance of Glvcosvlation
Glycosylation is one of the most important post-translation
modifications on proteins. However, due to their unique structural
complexities, and the absence of appropriate protocols to characterize their
structures, they were less understood [Dell 2001]. Moreover, proteins are
synthesized by the accuracy and constraints imposed by a template, while
their conjugated glycans are assembled through a series of separate
enzymatic steps each of which introduces variability defined by Golgi
trafficking and the dynamic aspect of resident cofactors [Taylor 2006; Varki
1999]. Thus, the products represent a series of closely-related structures,
usually referred as glycomers [Rademacher 1988]. A well-known example is
the glycoprotein obtained from hen's egg and identified as chicken ovalbumin.
This glycoprotein has a single N-linked glycosylation site, with over 40 unique
glycomers associated at that site, including high-mannose, hybrid, and
complex types [Harvey 2000; Zhang, Unpublished data].
Regardless of the challenging problems in structural characterization,
it becomes more evident that glycosylation is involved in numerous biological
activities, and plays an indispensible role in tissue and cell development
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[Lairson 2008; Varki 1999]. Glycosylation, as well contributes to the
conformational structure of proteins, and an excellent example is the human
CD2 glycoprotein located on the surface of killer T lymphocytes that mediates
binding to target cells [Recny, 1992]. Either mutation of the A/-glycosylation
site (Asn-65 to Glu-65) or complete removal of /V-glycans by PNGase F will
eliminate the binding ability to its receptor CD58 on target cells. Since this
glycosylation site lies almost on the opposite side of the binding domain, the
attached glycan residue does not participate in the binding directly, but it
seems to function as a receptor of positive charge of several neighboring
lysine residues (Lys61, 69, and 71). No A/-glycosylation was needed on this
site for rat CD2 since its 61 position is a negative charge amino acid glutamic
acid, being able to interact with other positive charge amino acids as well
[Taylor 2006]. In addition, the flexible nature of glycosylation appears to act
as a cover to protect against proteolysis. This is somewhat analogous to the
human influenza virus HA, which appears to gain more A/-glycosylation sites
after being circulated in the human population, and is proposed to protect
against host antibody recognition [Kaverin 2002]. Carbohydrate epitopes are
also the recognizing residues in cell adhesion and signaling. The serum
mannose-binding protein (MBP), also called mannose-binding lectin (MBL),
and mannose receptor on endothelial cells and macrophages, binds to
mannose and GlcNAc residues that are frequently found on the surface of
microorganisms, rather than human cell surface. Binding initiates a series of
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reactions for macrophages to internalize pathogens [Taylor 2006]. The
influenza virus HA recognizes the sialic acid-galactose residue on the host
cell and upon binding initiates virus entry [Stevens 2006b].
Another fundamental role exhibited by glycosylation is a control of
protein folding of newly synthesized glycoproteins. Calnexin and calreticulin
are two such chaperone molecules involved in this process, located in the
endoplasmic reticulum. This is initiated by the chaperone protein binding to a
glucose residue that terminates the 3-branched antenna of an A/-linked high
mannose glycan. The overall process guides properly-folded proteins to the
Golgi for glycan processing or shifts the misfolded proteins to a degradation
pathway [Taylor 2006]. Glycosylation is also involved in tissue development,
and altered glycan structures are associated with many disease states
[Gornik 2008; Zhao 2008]. Thus, the study of glycobiology includes the
characterization of structure and their functional relationships [Taylor 2006].
Molecular glycosylation occurs mostly on lipids and proteins where the
carbohydrates are referred to as glycans and the products glycoconjugates.
More specific terms are becoming popular with glycosylation of proteins and
lipids referred to as the glycoproteome and glycolipidome. There are two
major classes of glycans within the glycoproteome, the N-, and O-linked
glycans, according to the attachment amino acid residue of the sugar moiety.

3

1.2 Structure Features of N- and O-qlvcans
Glycans are assembled with monosaccharide building blocks. The
most common of which is a hexapyranoside. Because four of six carbon
atoms in a hexose have chiral centers, and each can exist in two
configurations, there are a total of sixteen possible hexoses. It would be an
extremely difficult task to determine their identity if all isomers existed in
nature, fortunately, only nine common monosaccharides have been found in
vertebrates [Varki 1999]. These include three hexoses (D-Glucose , Glc;
D-Galactose, Gal; D-Mannose, Man), one pentose (D-Xylose, Xyl), one
deoxyhexose (L-Fucose, Fuc), one acidic hexose (D-Glucuronic acid, GIcA),
two A/-acetamidohexoses (A/-Acetyl-D-glucosamine, GlcNAc;
A/-Acetyl-D-galactosamine, GalNAc), and one unique nine carbon
monosaccharide (/V-Acetylneuraminic acid, NeuAc). Representative
monosaccharides and their common abbreviations are shown in Figure. 1.1.
/V-glycans of proteins are attached to the amide nitrogen of asparagine
(Asn) residue by an A/-glycosidic bond. Five different A/-glycan linkages have
been reported [Spiro 2002] of which A/-acetylglucosamine to asparagine
(GlcNAcytfl-Asn) is the most common (Figure. 1.2) and is the only linkage
found in animal cells [Varki 1999]. N-glycosylation occurs on many secreted
and membrane-bound glycoproteins at the amino acid sequence (sequon)
Asn-XXX-Ser/Thr in which XXX can be any amino acid except proline. It is
important to note that this sequon is required for the receipt of a glycan.
4

However, the presence of this sequon doesn't always indicate glycosylation.
It was estimated that two thirds of those sequons published in databases are
most likely to be glycosylated [Ben-Dor 2004]. Therefore, these sites are
commonly referred to as potential A/-glycosylation sites.

D-Glucose (Glc)

N-Acetyi-O-Giucosamine (GicNAC)

D-Xylose (Xyi)

D-Galactose (Gal)

N-Acetyl-O-Galactosamine (GalNAc)

N-Acetyfneuraminic acid (NeuAc)

D-Mannose (Man)

L-Fucosa (Fuc)

D-Glucuronic acid (GicA)

•

i*r

Figure 1.1. Nine common monosaccharides found in vertebrates. A
commonly used abbreviation (three letter code) and unique geometric shape
are used to represent the different structures throughout this thesis [Varki
1999].
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Asn

GlcNAc

Core Structure

residue
in protein

High Mannose

Complex

Hybrid

Figure 1.2. Common types of /V-glycans and its core structure.
Attachment of A/-glycan (GlcNAc) to an asparagine (Asn) residue of proteins
via /^-linkage. Three different types of /V-glycans have been identified, high
mannose, complex and hybrid. Each contains the pentasaccharide core
Man3GlcNAc2 structure [Varki 1999].

All A/-glycans share a common pentasaccharide core structure,
Man[a(1-6)Mana(1-3)]Man^(1-4)GlcNAc^(1-4)GlcNAc^(1) (Figure 1.2) and
differing extensions to this core gives rise to three classification types; (1)
high mannose, in which only mannose residues are attached; (2) complex, in
which extending residues are initiated with GlcNAc; and (3) hybrid, in which
only mannose residues extend from the Man-6 arm, and GlcNAc extensions
from the Man-3 arm (Figure 1.2). Another common modification is the
addition of an /?(1 -4) GlcNAc to the central core Man (the one with /?(1 -4)
linkage to GlcNAc) of the complex glycans. Such structures are frequently
referred to as "bisecting". It is common to see other residues (fucose and
6

xylose) added to the core and they can be further extended into complicating
arrays (Hanneman, 2006).
O-glycosylation is the second major modification in which the sugar
moiety is linked through the hydroxyl group of serine (Ser) or threonine (Thr).
Unlike A/-glycosylation, O-glycosylation does not have an established sequon.
Thus, the task to define the exact location of O-glycosylation sites is
challenging due to the presence of numerous such residues in proteins. The
most common protein family exhibiting O-glycosylations is the mucins.
O-glycans are attached through an oc-linked /^-acetylgalactosamine (GalNAc)
moiety and such glycoproteins are ubiquitous secretions on cell surfaces and
in body fluids [Varki 1999]. Mucin type O-glycans are extended with residues
of galactose, A/-acetylglucosamine, fucose, and sialic acid, but not mannose,
glucose, or xylose. Eight common core structures of mucin type O-glycans
have been identified (Figure 1.3).

O
Core 1

V
Core 2

Core3

V
Core 4

?

P

5

9

P
3

Q
6

a
6

«
2_

Core5

Core 6

Core 7

Core8

Figure 1.3. Eight common core structures of mucin type O-glycans.

[Varki 1999]
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1.3 Biosynthesis of /V-linked Glvcans
The structural diversity of A/-glycans is a consequence of the
biosynthetic pathway that begins on the surface of the endoplasmic reticulum
(ER). This pathway can be divided into four distinct stages: (1) formation of a
lipid-linked precursor oligosaccharide; (2) en bloc transfer of the
oligosaccharides to a nascent polypeptide; (3) trimming of oligosaccharides
in the ER and Golgi; (4) addition of new sugars in the medial and frans-Golgi.
All eukaryotes share the first three steps of A/-glycosylation, but greater
glycan complexity is observed in more highly evolved species due to
extensive processing that occurs in the Golgi [Prien 2009].
A/-glycosylation begins not with a polypeptide substrate, but rather with
the polyisoprenoid lipid, dolichol phosphate (Dol-P). The formation of the
dolichol-linked oligosaccharide precursor, Glc3MangGlcNAc2-P-P-Dol, is
constructed on both sides of the ER (Figure 1.4). The assembly of this
complex molecule is the consequence of 14 enzymes which may lack
exacting specificity [Wiswall, unpublished results].
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Figure 1.4. Synthesis of the lipid-linked oligosaccharide precursor
Dol-P-Glc3Man9GlcNAc2 in the ER.

The dolichol-linked oligosaccharide precursor is transferred to the
protein in the lumen of ER, which is catalyzed by the
oligosaccharyltransferase enzyme complex. The nascent glycoprotein
undergoes immediate quality control processing before moving to the Golgi.
Glucosidase I and II in the ER remove the terminal and penultimate glucose
residues, which is followed by binding to the quality control lectins,
calnexin/calreticulin, to insure proper folding. Glucosidase II acts again on
those correctly folded by removing the third glucose and prepares the
glycoprotein for processing. The ER «(1,2) mannosidase I hydrolyzes the
middle terminal mannose from Man-6 arm to generate Protein-Man8GlcNAc2
complex (B, Figure 1.5) before the glycoprotein exits the ER. Once the
glycopeptide enters into the Golgi, another three mannose residues can be
removed by a series of Golgi mannosidases to generate
Protein-Man5GlcNAc2 complex (C, Figure 1.5). High-mannose type glycans

will remain on the glycoprotein if no processing occurs. Recent results in our
laboratory have provided structural evidence that processing is not as
exacting as often described with multiple isomeric intermediate products
[Prien 2009].
As for complex and hybrid type structures, the processed glycan
linked protein is rebuilt according to the specificity of the tissue. This
rebuilding is initiated by the GlcN Ac-transferase I; an enzyme that adds one
GlcNAc residue to Man-3 arm (D, Figure 1.5). Following the addition, other
mannosidases in the Golgi continue to remove the remaining two mannoses
(outside the core) on the Man-6 arm. Further addition of GlcNAc can be
obtained by different GlcNAc-transferases in Golgi, providing cell specificity
and branching pattern to the product glycans. Elongation on the GlcNAc
antennae is provided by the addition of a Gal and sialic acid residue (G, H,
Figure 1.5). The resulting sialic acid-galactose moiety is often a capping
structure (no more elongation), which is also the receptor of many pathogens,
such as influenza virus.
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1.4 Glvcome and Structural Analysis of Glvcans by MS"
The total complement of glycans in a cell or organism is defined as the
glycome. Genomic DNA sequences dictate the primary structure of proteins.
In contrast, glycan structures are not encoded directly by DNA sequences. In
fact the glycan structure is determined by the resident glycosyltransferases in
the Golgi varies between cell types and at different stages in development,
thus, the glycome is a characteristic of a particular cell type at a specific state.
Importantly, glycosylates is known to be altered during many disease
conditions, such as cancer [Zhao 2008; Prien 2008; Dennis 1999]. Thus,
analysis of glycome provides a basis for understanding the functions of
glycans in cell differentiation and diseases.
Since glycans have different physical and chemical properties than
peptides and exhibit glycomer variations, both N- and O-glycans must be
released and characterized differently. A/-glycans can be released from
asparagine using a bacterial enzyme known as peptide-/V-glycosidase
(/V-glycanase F, PNGase F). PNGase F is able to remove all types of
A/-glycans from the peptides, except for some modification (such as 3-Fuc)
on the core innermost GlcNAc, which is usually observed in plants, insects,
and parasites [Hanneman 2006]. At this time there has been no comparable
O-glycanases reported, and O-glycans must be released by chemically. The
classical method employs strong base (NaOH) and a reducing agent NaBH4,
which converts the released glycan to its corresponding alditol in situto
12

prevent any "peeling" reactions [Karlsson 2002]. Alternative release
procedures have been established for both N- and O-linked glycans using
hydrazine at different temperature, but yields are compromised [Merry 2002].
Although many strategies and methods have been presented to
characterize glycan structure [Zaia 2009; Harvey 2009a; Harvey 2006; Zaia
2004], structural analysis remains a daunting task. One difficulty lies in the
structural complexity of each individual glycan. A complete glycan structure
should include the following information; composition, monosaccharide
identity, anomeric configuration, intervening linkage and, branching
information (generally referred as topology). Another problem is the
heterogeneous of glycans (referred as glycomers). Since glycans share
similar chemical characteristics, it is challenging to resolve the glycans by
chromatographically, especially for structural isomers. Thus, due to the
above practical problems, the reporting of a partial sequence, assumed
motifs, arrays absent of linkage and branching information, multiple
structures enclosed in brackets are currently acceptable in scientific reports.
Numerous reports have been published introducing alternatively
strategies for structural analysis, most frequently using combinations of
chromatography [Merchref 2008; Novotny 2008; Volpi 2008], lectins
[Gemeiner 2009; Hirabayashi 2008], and enzymes [Park 2008; Domann
2007]. Moreover, the lack of exacting specificity offered with many biological
tools (lectins) and their inability to define positions of antennal release
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(exoglycosidases) coupled with the ultimate need for product characterization
introduce irresolvable complications. As we will discuss in chapter 4, a lectin
approach is neither reliable nor accurate to determine sialic acid galactose
linkage. Our group has established a unique strategy to characterize glycan
structure by multiple steps of disassembly on permethylated glycans in ion
trap mass spectrometry (MSn) [Prien 2009; Prien 2008; Ashline 2007;
Hanneman 2006].
Glycan methylation has long been a reliable derivative for
carbohydrate analysts. Methylated products exhibit improve carbohydrate
signals in mass spectrometry, and provide extensive structural detail upon
sequential mass spectrometry (MSn) of product ions [Ashline 2005]. This
strategy has been successfully demonstrated on identification of novel
/V-glycans from therapeutical IgG [Ashline 2007], unusual core-modification
of A/-glycans from C. elegans [Hanneman 2006], and cancer biomarkers
[Prien 2008]. An example that has further demonstrated the power of
sequential MSn was an application characterizing the isomeric glycan
structures detected in bovine ribonuclease B (RNase B) [Prien 2009]. The
glycomers Man5GlcNAc2, Man7GlcNAc2 and Man8GlcNAc2 from this
glycoprotein were long established to posses seven isomers, one, and three
each for the latter two, respectively. There were multiple reports supporting
this observation, most recently by a combination of HPLC coupled with
FTICR-MS, [Zhao 2008; Costello 2007]. Recent studies in our laboratory
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have identified thirteen isomers from the same three glycomers, six
previously unreported (Star-highlighted, Figure 1.6) [Prien 2009]. Additionally,
incomplete a-glucosidase activity on the total glycans of RNase B appears to
account for these isomeric structures [Prien 2009]. The detail of this strategy
will be discussed in Chapter 2 and Chapter 3 to identify A/-glycan structures
from EP glycoprotein and neuraminidase of influenza virus.

Figure 1.6. Thirteen isomeric glycans were identified from bovine
ribonuclease B. Six of them were previously unreported (designed as red
star) [Prien 2009].

Key features that make MSn a valuable strategy for understanding
carbohydrate structures can be summarized as follows: (1) Samples
prepared by methylation and reduction places monomers in a glycan array,
thus, termini, extending, and branched residues can be defined. (2)
Pathways of disassembly can be directed which defines domains of structure
15

providing antennal sequence. (3) Fragments exposed during disassembly
that fail to define a single topology are an indicator of structural isomers,
which may be isolated and selectively characterized. (4) A searchable library
of small oligomer fragments provides the details of linkage, monomer ID, and
stereochemistry.
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CHAPTER 2
Characterization of Novel /V-Glycans of the EP
Glycoprotein from the Mollusc: Mytilus Edulis

2.1 Introduction

Biomineralization
Biomineralization is the matrix-mediated processes by which living
organisms regulate and organize mineral deposition [Lowenstam 1989; Seed
1980]. These processes involve the selective extraction and uptake of
inorganic elements from the local environment and their incorporation into
functional structures under strict biological control such as seashells, bone,
teeth, ivory, corals, etc. These structures fulfill a diversity of biological
functions [Mann 2001] including protection, exoskeleton (eg. seashell),
endoskeleton (eg. invertebrate bone), and gravity receptor (eg. inner ear
bones in mammals), optical imaging (eg. calcite lens in the compound eyes
of trilobites), and temporary storage (eg. amorphous calcium carbonate in
plant leaves to store calcium). The mineral crystals formed by the organisms
are usually referred to as biominerals. Biominerals has two unique features
distinguishable to other inorganic deposit minerals. First, the biominerals
have unusual, diverse, complex, external morphologies, and sometimes even
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chirality. Second, many biominerals are actually composites or
agglomerations of crystals separated by organic material/matrix. Generally,
living organisms regulate mineralization via the use of organic
macromolecules (proteins, polysaccharides). These macromolecules are
responsible for nucleation, growth regulation, and growth cessation of the
mineral crystals [Belcher 1996; Addadi 1992; Mann 1988].
The EP Glycoprotein from Mvtilus Edulis
Mytilus edulis, commonly known as blue mussel, is one of the most
extensively studied marine organisms and found worldwide in most polar
waters. In the shell of the mollusc Mytilus Edulis, calcium carbonate is the
dominant composition accounting for 95 - 99% by weight [Yin 2005]. The
exterior of the shell is covered by a thin layer of sclerotized protein, termed
the periostracum. A series of compartments are involved in the shell
formation. The most important compartment is the inner shell surface, the
extrapallial cavity and the outer mantle epithelium [Crenshaw 1980]. The
extrapallial (EP) fluid is secreted by the outer mantle epithelium cells and fills
the extrapallial cavity, the space between the shell and the outmost visceral
organ of the mantle. The EP fluid contains proteins, carbohydrates, and
amino acids, and is also believed to be supersaturated with respect to the
shell minerals. Its anatomical location and biomolecular components of the
EP fluid imply its key role in the formation of the shell in vivo [Misogaines
1979; Weiner 1977].
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The EP glycoprotein, the major protein component of EP fluid, was
isolated and characterized as a 213 amino acid protein with a single
A/-glycosylation site [Yin 2005; Hattan 2001]. This glycoprotein comprises
56% of the total protein in the EP fluid and the carbohydrate accounts for
14.3% in the EP glycoprotein by weight. The EP protein is acidic (PI = 4.43)
and rich in histidine (11.1%) as well as in Asp and Glu residues (25.2 % total)
[Hattan 2001]. The intriguing property of this glycoprotein is its
calcium-binding-induced self-assembling into a series of higher order
protomers [Hattan 2001]. Circular dichroism results show that the
protein-calcium binding/protomer formation is coupled to a significant
rearrangement of the protein's secondary structure [Hattan 2001]. Besides
Ca2+ ion, the EP glycoprotein also binds to other divalent ions, such as Cd2+,
Cu2+, Mn2+, and Mg2+ [Yin 2005]. Although the presence of several carboxylic
acid residues (eg. Asp) may serve as metal ion binding sites; the binding
domain of the metal ions can not be fully defined only by the protein
backbone sequence [Yin 2005].
The EP glycoprotein sequence has indicated that it may be the same
protein as a heavy metal binding protein (HIP) from the hemolymph of
M.edulis [Yin 2005] and as a histidine-rich glycoprotein (HRG) from the
plasma of M. edulis [Nair 1999]. It seems that these proteins are widely
present in the various tissues of M. edulis, and also in other marine animals
[Nair 1998], suggesting its various biological functions besides shell
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formation such as: metal ion transportation, de-toxification, etc. [Yin 2005;
Hattan 2001; Nair 2001 a; Nair 2001 b; Nair 2000]. The key feature of the EP
glycoprotein is its strong affinity with many metal ions such as: Cu 2+ , Cd 2+ ,
Mg2+, Mn 2+ , Hg 2+ , Ni 2+ , Pd 2+ , Zn 2+ , and Ca 2+ [Devoid 2007; Hattan 2001; Nair
2000]. The metal ion binding ability of this protein is remaining even after heat
denaturation and polyacrylamide gel electrophoresis [Nair 1999], suggesting
the chelation between protein and metal ions are not completely dependent
on the proximity of acidic amino acids in the native conformation. Given the
carbohydrate components having acidic residues and multiple antennae
[Naggar 2000], it is reasonable to suspect that /V-glycosylation may take part
in the metal ion binding directly. Therefore, the complete structural
information of A/-glycans is essential to understand the EP glycoprotein's
biological functions. The structures of A/-glycans from EP glycans have
proven to be quite unique and have eluded past attempts at characterization
[Yin 2005; Naggar 2000]. Herein we resolve the structural ambiguity by
combining a series of techniques such as: accurate mass measurement,
GC/MS monosaccharides composition analyses, chemical modification,
positive ion and negative ion MSn disassembly.

New MS-based Strategy to Characterize Complex-type /V-qlvcans
The complete structural information of glycans should include
following information such as: monosaccharides identities, the linkage
positions of inter-residues, anomericity, and array topology, where array
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topologies describe linear and branching sequence information as discussed
in Chapter 1. As for non-mammalian system, glycan structural
characterization may be particularly challenging because some unusual
monosaccharide residues may be encountered; or the monosaccharides may
be modified by natural methylation or carboxylation, etc [Voisin 2005;
Srikrishna 2005; Puanglarp 1995]. In these cases, the primary task will be
identifying the possible monosaccharides identities and compositions.
Therefore, reliable techniques have to be sought to determine the
monosaccharide compositions, for example: combining GC/MS and accurate
mass measurement. GC/MS is a classical method on carbohydrate
composition analysis and linkage analysis [Levery 1987].
Negative ion MS/MS on small oligosaccharides has been
demonstrated to provide some complementary structural information such as:
chain location, branching pattern and sialic acid linkage [Chen 2008; Yu 2006;
Chai 2006; Chai 2005; Chai 2002; Chai 2001]. Recently this technique
gained extensive attention and has been reported to provide unique fragment
ions of multi-antennary A/-glycans [Harvey 2005a; Harvey 2005b; Harvey
2005c], difficult to obtain through positive ion fragmentation. A good example
is the formation of ion D [Harvey 2009b; Harvey 2008a; Harvey 2005b;
Harvey 2005c] containing the moiety of the core mannose and 6-branching
mannose residues and associated antennae, which is diagnostic to
determine the Man-6 branching composition. This information is usually
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difficult to obtain under positive ion CID fragmentation pathway due to the
labile linkage between 6-mannose and the neighboring antennary GlcNAc.
Due to the acidic property of the glycans from EP protein, it may be easy to
seek the branching information via negative MSn.
So far many mass spectrometric strategies have been proposed to
characterize glycan structures [Harvey 2009a; Zaia 2009; Merchref 2009].
The most widely-used strategies are combining both exoglycosidase
digestion and mass spectrometry or HPLC before and after digestion. The
monosaccharides and their linkages are revealed by the specificity of the
employed enzymes, and the general topology is deduced by the change in
the property being measured (chromatographic retention time, mass, etc.).
Although popular, these strategies are highly dependent on a readily
available source of the exoglycosidase in a pure state. Furthermore, the
terminal residues are removed by the specific enzyme step by step, some
structural information may be lost during the process, especially for those
cases with multiple positions available to attach the terminal residues
removed by enzymes. Most importantly, specific enzymes may not be
available for less common monosaccharide residues such as galacturonic
acid and ^-acetylgalactosamine, or extra modification on the common
monosaccharides, such as methylation, acetylation, etc. Sometimes
biosynthetic pathways have to be fully considered to propose the most
plausible structure [Dell 2001]. Therefore, a general strategy is indeed
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needed to identify the complete glycan structures with unusual
monosaccharides residues and other non-carbohydrate modifications,
especially for those less-well studied species. A new strategy is proposed
herein which combines various modern mass spectrometry techniques and
chemical modifications to characterize the A/-glycans of the EP glycoprotein
from the mollusk: Mytilus edulis. This strategy includes following techniques:
GC/MS and accurate mass measurement to define the monosaccharide
identities and compositions; positive MSn on deuterated permethylated
derivates of glycans to characterize the antenna sequence and inter-residue
linkage information; negative MSn on native glycans to determine the general
branching mode (topology).

2.2 Experimental Procedures
Materials and Reagents
Blue mussels, M. edulis, were collected from the waters off the
northeast coast of the United States (Dover Point, NH), and the EP protein
was extracted and purified following procedures as described previously
[Hattan 2001]. The enzyme glycerol-free PNGase F and associated reagents
(10 x denaturing buffer, 10X NP-40, 10X G7 buffer) were purchased from
New England Biolabs (Beverly, MA); Dowex 50W X 8 hydrogenform
cation-exchange resin, dimethyl sulfoxide, sodium hydroxide, iodomethane,
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iodomethane-d3, iodine; sodium borohydride, sodium borodeuteride,
tetrahydrofuran, toluene and ethanol were obtained from Sigma-Aldrich (St.
Louis, MO); chloroform, acetonitrile, and methanol were from EMD chemicals
(Gibbstown, NJ); water was from J. T. Baker (Phillipsburg NJ). Chemicals
and solvents were of ACS or HPLC grade.
Glycan Sample Preparation
A/-glycans were enzymatically released from the purified EP
glycoprotein by PNGase F following the procedure according to the
manufacture instruction. In briefly, 1 mg dried EP protein was dissolved in 50
jj.L 1X protein denature buffer and incubated at 100 °C for 45 minutes.
Subsequently, 5 JJL of 10X NP-40 and 5 u.L of 10X G7 buffer were added into
the solution, along with 1 -2 uL PNGase F. The enzyme reaction was kept at
37 °C for at least 10 hours. The glycans were separated from protein,
enzymes and detergents by passage through a C-18 Sep-Pak cartridge
(Waters, Milford, MA). In selected cases the A/-glycans were reduced with
sodium borohydride (10 mg/mL NaBH4 dissolved in 0.01 M NaOH) at room
temperature overnight and desalted with a column of Dowex 50W
cation-exchange resin. Further purification step was carried out on a
hand-packed cellulose column (Medium fibrous, Sigma, St. Louis, MO) in an
organic solvent of 1-butanol: EtOH: H20 (4:1:1, v/v/v) [Shimizu 2001]. Briefly,
the glycan samples were taken up in 200 uL of EtOH: H20 (1:1, v/v), and
mixed with 2 mL of the organic solvent, and then applied onto the cellulose
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column. The column was washed with 4 mL of the organic solvent before the
glycans were eluted with 4 mL of EtOH: H20 (1:1, v/v). The reduced glycans
were dissolved in DMSO and permethylated by treating with powdered
sodium hydroxide with iodomethane using the method previously reported
[Ciucanu 2003]. Deuterium permethylation was performed employing the
same procedure except that iodomethane was replaced by iodomethane-d3.
Conversion of Glucuronic Acid to Glucose
Direct reduction of the carboxylic acid group to the primary hydroxyl
group was carried out using the method reported by Kanth and Periasamy
[Kanth 1991]. Briefly, the native glycans were dissolved in fresh distilled
tetrahydrofuran, and sodium borodeuteride was slowly introduced to form a
suspension. After gas evolution ceases, a small amount of iodine was added
and the reaction was allowed to stir overnight at 50 °C. Acetic acid was
added to stop the reaction in the ice bath, and excess borate was removed by
co-evaporation with 2 mL ethanol, 3 x 2 mL of 1% acetic acid in methanol,
and 2 x 2 mL toluene. The product was desalted using Dowex 50W
cation-exchange resin and permethylated and stored for MSn analysis.
Mass Spectrometry
Mass spectrometry was performed on a Thermo linear ion trap LTQ
instrument, (Thermo, Waltham, MA) equipped with a nanospray ESI source.
Native (without permethylation) glycans were dissolved in methanol: H20 (1:1)
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containing 0.5% acetic acid and permethylated glycans in 100% methanol for
mass spectrometry. Samples were infused at flow rates ranging between
0.30 and 0.60 nL/min, and spectra were collected using Xcalibur 1.4 software
(ThermoFinnigan). Accurate mass determination of the native glycans was
obtained under negative ion mode using the ultra-zoom scan function and
off-line internal mass calibration against the disialylated glycan
(Hex)2(HexNAc)2(NeuAc)2+(Man)3(GlcNAc)2 from IgG (Sigma-Aldrich, St.
Louis, MO). All positive ion and negative ion MSn spectra were acquired at
25-40% normalized collision energy with capillary temperature at 230 °C, and
the activation Q and activation time were set at their default values, 0.25 and
30 ms, respectively.
GC/MS Monosaccharide Composition Analysis.
GC/MS composition analysis was performed on a Polaris Q TraceGC
Ultra (ThermoFinnigan, Waltham, MA) equipped with a DB-5, 30 m x 0.25
mm x 25 u.m column (Restek, Bellefonte, PA). The overall experiment
condition was following the partially methylated alditol acetates (PMAAs)
linkage analysis procedure reported by Levery [Levery 1987]. Instead of
permethylated glycans, the native glycans was hydrolyzed, reduced, and
acetated for GC/MS analysis. In summary, the dried glycans was dissolved
in 100 ^iL of 0.5 N H2S04 in 90% acetic acid, and incubate at 80 °C for 6 hrs.
Then the reaction solution was neutralized by 130 ULL of 0.5 N NaOH and
repeatedly dried with several additions of ethanol. The hydrolyzed

26

monosaccharides were reduced with NaBD4 (10 mg/mL in 0.01 N NaOH)
overnight and the excess borate was removed by several addition of
methanol and dried. Following the acetylation was carried out with acetic
anhydride at 100 °C for 2 hrs. Excess acetic anhydride was removed by
several addition of toluene and dried under nitrogen stream. The residues
were partitioned between chloroform and water layers. The chloroform layer
was collected, and dried, and reconstituted in 20 u.L hexane. Take 1 ja.L for
GC/MS. Because the hexauronic acid moiety was modified naturally by the
methoxyl group, two uronic acid standards, GIcA and GalA, were methylated
using the same procedure as permethylation [Ciucanu 2003], rather than
acetylated after hydrolysis and reduction. The temperature program for gas
chromatography was set as below: hold at 40 °C for 1 minute, and then
elevate to 130 °C with the ramp 30°C/min. After reach to 130 °C, the ramp
was decreased to 4 °C/min until 250 °C.

2.3 Results
Mass Measurement of Glycan 1 and GC/MS Composition Analysis
The A/-glycan pool released from the EP glycoprotein showed
prominent three glycans signals (1- 3) with the major component glycan 1
(Figure 2.1). All the glycans showed good signals under negative ion ESI-MS
with multiple negative charge states ranging from 3 to 5 (Figure 2.1),
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indicating the presence of multiple acidic groups: such as carboxylic acid,
phosphate groups, or sulfate groups, etc. Deducing the molecular weight of
these A/-glycans (Figure 2.1) from the MS profile, it suggested that these
A/-glycans may contain unusual modification or residues because common
nine monosaccharides as discussed in Chapter 1 did not fit their molecular
weights. Therefore, the primary task was to determine the possible
substituent compositions of these glycans. The negative charge groups were
proposed to be mono-methoxyl-phosphate groups (Figure 2.2) previously
[Naggar 2004] according to the nominal mass of glycan 1 (M.W. 4027).
Whereas, disassembling of glycan 1 by negative ion MSn show a series of
prominent neutral loss of 190 Da [MS2 on 1006.2 (4-)->1278.3 (3-), A = 190;
MS3 on 1006.2 (4-)-»1162.0 (3-)-»1648.5 (2-), A = 190] and 32 Da [MS2 on
1006.2 (4-H998.2 (4-), A = 32; MS3 on 1006.2 (4-)-»1162.0 (3-)-»1151.4 (3-),
A = 32] (see appendix for spectra), suggesting the presence of terminal
mono-methoxyl-hexauronic acid moiety (C7H10O6 M.W. = 190). In order to
determine the exact molecular weight of glycan 1 to clarify this uncertainty,
accurate mass measurement was performed with mass calibration against
the internal standard glycan: Man3GlcNAc4Gal2Sial2 from human IgG using
LTQ nano-ESI ultra-zoom scan technique (Figure 2.2). The adjusted
molecular mass of glycan 1 was 4027.5441 Da, fitting to a composition
(mono-MeO-HexA)4(HexNAc)io(Hex)3(DeoxyHex)5 (4027.4589, dif. 21 ppm)
rather than the previously proposed composition:
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(mono-MeO-phospateMHexNAcJioCHex^DeoxyHex)! (4027.0409, dif. 125
ppm) (Figure 2.2), both of them having the identical nominal mass: 4027 Da.
To further confirm the presence of the mono-MeO-HexA residues and other
monosaccharides, the GC/MS monosaccharide composition analyses were
carried out. Due to the natural methoxyl modification on HexA moiety, the
total EP glycan pool were hydrolyzed to monosaccharide residues by strong
acidic solution, then reduced with sodium borohydride and per-methylated
and compared with two HexA standards (glucuronic acid and galacturonic
acid) following the exactly same treatment. According to this result, the HexA
moiety was assigned as glucuronic acid unambiguously (Table 2.1). No
isomeric GalA residue was detected. Because of the absence of GalNAc, Gal,
Glc, and Rha residues (Table 2.1), it was evident to assign HexNAc, Hex,
and DeoxyHex as following: GlcNAc, Man, and Fuc, respectively, according
to the GC/MS results using the acetylated derivatives (See Appendix for
additional Spectra). Thus, the monosaccharides composition of glycan 1 was
defined as (mono-MeO-GlcA)4(GlcNAc)io(Man)3(Fuc)5 unambiguously. The
presence of ten GlcNAc residues and only three mannose residues strongly
suggested that glycan 1 was a complex type A/-link glycan with multiple
antennae. Thus, next step will be identifying each antenna sequence.
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Figure 2.1. Negative ion LTQ ESI-MS of total enzymatically released
AMinked glycans from the EP glycoprotein. All the peaks are multiple
charges and the charge state of each individual peak is annotated in the
parenthesis. Three major glycans (1-3) are observed and each glycan may
have multiple peaks due to the presence of various charge states. The
molecular weight (M.W.) of each glycan is calculated and showed in the
right-top panel.

(+) MS" analysis of Deuterated Permethvlated Glycan 1
As demonstrated in our previous report, permethylated glycan show
better signals compared to native glycan [Reinhold 1995; Ashline 2005].
More important, blocking the free hydroxyl group with a methoxyl group, it
provides the opportunity to obtain the inter-residue linkage information with
MSn disassembling pathway [Ashline 2005]. The monosaccharide
composition of glycan 1 [(mono-MeO-GlcA)4(GlcNAc)io(Man)3(Fuc)5 ] clearly
indicated that glycan 1 was a complex type A/-linked glycan. In general under
positive ion collusion-induced-dissociation (CID) fragmentation pathway, the
antenna B ion is abundant and distinguished in the low mass range in MS/MS
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Table 2.1: GC/MS monosaccharide composition analyses of EP glycans.
n/a : not applicable. Monosaccharide identities were assigned confidently by
comparison of both retention time and El mass spectra (See appendix for
spectra)
STD
Rha
Fuc
Man
Glc
Gal
GalNAc
GlcNAc
GIcA
GalA

Acetylated derivative Methylated derivative
Retention time (Min) Retention time (Min)
18.98
19.23
24.98
25.27
25.49
29.17
28.61
12.13
13.16

,s

100-,

EP Glycan
(Min)
n/a
19.23
24.98
n/a
n/a
n/a
28.61
12.13
n/a
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Figure 2.3. Positive ion ESI MS/MS (-> 1706.8) spectrum of deuterium
methylated glycan 1. Distinguished antenna B ion (m/z 952.6, monoisotopic)
is abundant in the low mass range (<1200 Da) because the glycosidic bond
between chitobiose core and complex glycan antenna's GlcNAc is easily
broken down under positive ion CID fragmentation mode. All peaks larger
than 1200 Da are multiple charge ions, corresponding to large fragments. All
fragment ions contain a sodium atom.
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of permethylated A/-glycan spectra due to the labile nature of the glycosidic
bond between the core Man-3 or Man-6 and the neighboring GlcNAc in
antenna. In order to locate the naturally occurring methoxyl group position,
the deuterium methylated derivative was prepared in parallel and subjected
to MS/MS fragmentation, showing a distinguishing deuterated antenna B ion
(m/z 952.6, Figure 2.3), which accounts for a composition
[(mono-methoxyl-GlcA)(GlcNAc)2(Fuc)] (Figure 2.3).
Antenna sequence was obtained by further MSn disassembly of the
deuterated methylated B ion. First of all, the evident ion at m/z 920.5 (A = 32)
from MS3 fragmentation pathway (1078.6->952.6, Figure 2.4) clearly
confirmed the presence of one natural methoxyl group in the antenna.
Neutral loss of a CD3OH moiety was also observed at m/z 917.5 (A = 35), but
relatively low in abundance compared to the loss of a CH3OH molecule,
indicating the loss of CH3OH was favored for some reason. Further
disassembly of ion m/z 920.5 showed a dominant ion at m/z 770.5 in MS 4
spectrum (1078.6^952.6^920.5, Figure 2.4, inset), indicating the GIcA
moiety was the terminal monosaccharide and the methoxyl group located at
C-4 of GIcA (Scheme 2.1). Therefore it can be explained rationally that the
neutral loss of 32 Da is favored due to the formation of a conjugated double
bond (C-4 and C-5) with the carboxyl ester group at C-6 in GIcA. Furthermore,
the secondly abundant ion at m/z 681.4 (-Ci2D12H905N, A = 271) from MS3
fragmentation (1078.6^952.6, Figure 2.4) indicated the presence of a
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non-reducing end terminal GlcNAc due to the labile nature of the GlcNAc
glycosidic bond. In addition, the most abundant ion at m/z 789.5, which
comes from the retro Diels-Alder fragmentation of internal GlcNAc moiety,
indicated either C-4 or C-6 of internal GlcNAc was linked by other residues.
Further fragmentation of this ion showed a dominant fragmentation ion at m/z
665.4 (1078.6->952.6->789.5, Figure 2.5a), which derived from a [1,7]
sigmatropic hydrogen rearrangement [Lee 2004] (Scheme 2.2), suggesting
the other three residues attaching to C-4 of the internal GlcNAc. Given the
presence of both terminal GlcNAc and GIcA residues, the Fuc residue was
the only choice for the core branching residue connected by other three
monosaccharides in the antenna. Further MS5 disassembly of the ion at m/z
665.4 (1078.6-*952.6->789.5->665.4, Figure 2.5b) showed a distinguishing
fragment ion at m/z 322.2, indicating the GIcA moiety connected to C-4 of the
branching Fuc residue. While the abundant ion at m/z 378.2, most likely
came from a [1,5] sigmatropic hydrogen rearrangement (Scheme 2.3),
showing that the terminal GlcNAc was attached to C-3 rather than C-2 of the
branching Fuc. Another MSn fragmentation pathway containing the GlcNAc
and Fuc disaccharides moiety also supported the notion that both terminal
GlcNAc and GIcA attaching to C-3 and C-4 of the branching Fuc in the
antenna, respectively (Figure 2.6).
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the C-6 carboxyl group in GIcA. All fragments are single charge and contain
one sodium atom.
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In order to further confirm the presence of GIcA residue, the carboxyl
group (-COOH) in the GIcA was reduced to the primary deuterated hydroxyl
group (CD2OH) with NaBD4 and l 2 [Kanth 1991]. Reduced products were
then permethylated and subjected to positive ion MSn analysis. An evident
antenna B ion was observed at m/z907.5 in the MS/MS spectrum (->1630.6).
Further fragmentation of this ion at m/z 907.5 confirmed the presence of
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terminal Glc (Figure 2.7). Therefore, the antenna sequence was
characterized unambiguously as 4-0-methyl-GlcA(1-4)[GlcNAc(1-3)]
Fuc(1-4)GlcNAc. This unique antennary sequence suggested that glycan 1
contains four identical antennae with a single fucosylated core structure
{4-0-methyl-GlcA(1 -4) [GlcNAc(1 -3)]Fuc(1 -4) GlcNAc}4+Man3GlcNAc2Fuc.
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Figure 2.5. ESI MS" analyses of two ions m/z 789.5 (A, -»1076.8 -»952.6
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Since glycans were released by PNGase F, it can be deduced that
core fucose was in C-6 position of the innermost GlcNAc. But the position of
each antenna remains unknown.
Negative Ion MS" Analysis of Glvcan 1 to Define the Branching Mode
Negative ion MS/MS techniques have proved to be most useful to
determine core fucose linkage and branching patterns [Harvey 2008; Harvey
2005b; Harvey 2005c]. Although the exact fragmentation mechanism was
obscure, repeated and reliable diagnostic ions such as ion E, ion D [Harvey
2005b; Harvey 2005c] have been observed consistently in many large
A/-glycans and been recently summarized by Harvey etal. [Harvey 2009b;
Harvey 2008]. The distinguished 24A7 ion at m/z 928.8 from MS/MS spectrum
(->1005.9) of the native nonreduced glycan (Figure 2.8) indicated the core
fucose was attaching to C-6 of ultimate GlcNAc [Harvey 2008; Harvey 2005b;
Harvey 2005c], which was in agreement with PNGase F enzyme activity. To
obtain individual antenna's specific location to the Man-3 or Man-6 arms,
negative ion MSn on the reduced native glycan was carried out. In the MS/MS
spectrum (Figure 2.9), a distinguishing D ion at m/z 903.3 and 03A5 ion at m/z
867.3 showed that two antennae were attached to Man-6 arm [Harvey 2008],
suggesting that the other two antennae were attached to Man-3 arm. Further
MS3 fragmentation on C4 ion at m/z 831.3 (->1006.5->831.3) show a
relatively abundant E ion at m/z 792.2 [Harvey 2005b; Harvey 2005c]; while
MS4 disassembling on C4 ion m/z 831.3 (->1006.5-»903.3->831.3), the
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specific pathway from Man-6 arm, lack that diagnostic E ion (Figure 2.10a
and 2.10b). The presence of E ion from ->1006.5->831.3 pathway [Harvey
2005b; Harvey 2005c], mainly from Man-3 arm, showed the two antennae
connected to C-2 and C-4 of Man-3 arm, respectively. While the absence of E
ion from Man-6 arm pathway may suggest two antennae most likely attach to
C-2 and C-6 of core Man-6, respectively, not same as the Man-3 arm.
Therefore, the complete structure of glycan 1 was characterized as shown in
figure 2.11.

Structural Characterization of Minor Glycan 2
The monosaccharides composition of glycan 2 was defined as
(mono-MeO-GlcA)5(GlcNAc)i2(Man)3(Fuc)6 according to its molecular weight
(4769.4 Da, Figure 2.1). Positive ion MS/MS fragmentation on deuterated
permethylated peak shows that glycan 2 has the same antenna B ion as
glycan 1. Further MSn disassembly of the antenna B ion show the exact
fragmentation pattern as 1, indicating that the antenna sequence was the
same as 1: 4-0-methyl-GlcA(1-4)[GlcNAc(1-3)] Fuc(1-4)GlcNAc. Then it was
evident to deduce that glycan 2 was a penta-antennary complex A/-glycan in
which three of them were assigned at Man-6 arm and the other two antenna
at Man-3 arm according to the specific D and E ion from (-) MSn analyses
(See appendix for spectra).
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Structural Characterization of Minor Glycan 3
Negative ion MS/MS spectrum of glycan 3 (M.W. 4667.6, Figure 2.1)
revealed that glycan 3 has the same fragmentation pattern as glycan 1
except fori 60 Da increasing in glycan 3 (See Appendix for spectra),
suggesting an extra mono-methyl-O-Fucose moiety present in the antenna
composition. This assumption was further supported by the presence of the
proposed B ions from both permethylated and deuterium methylated
derivates (Figure 2.12a and 2.12b). Further fragmentations on the B ion
indicated the antenna sequence (Figure 2.13a and 2.13b). Ions m/z 834.5
and 905.5 in the permethylated MS3 spectrum suggested the presence of
one terminal GlcNAc and one terminal Fuc residue (Fig 2.13a). The abundant
ion m/z 936.5 came from the retro-Diels-Alder fragmentation of internal
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GlcNAc, suggesting the internal Fuc1->4GlcNAc linkages. Similar fragment
ions were observed in the deuterium methylated glycan (Fig 2.13b); in which
distinguishing ions at m/z 1097.8 and 947.6 indicated one naturally occurring
methoxyl group locating at C-4 of GIcA same as glycan 1. These data
suggested the mono-methyl-O-Fuc residue should be located at one of the
following positions: C-2 of GIcA; or C-2 of core Fuc; or C-6 of internal GlcNAc.
The abundant ion m/z 818.5 derived from sigmatropic [1.7] hydrogen shift
rearrangement in MS4 spectrum of ion m/z 936.6 (MS4 pathway:
1872.9->1094.0->936.5, Fig 2.14a) showed that the extra
mono-methyl-OFuc residue was attached to C-2 of GIcA. Moreover two
small ions m/z 429.2 and 447.3 further indicated that mono-methyl-O-Fuc
group was attached to GIcA residue. This notion was also supported by
another MS4 fragment ion at m/z 687.5 (1872.9-^1094.0^905.5, Fig 2.14b),
in which the terminal GIcA moiety was lost including the C-2 hydroxyl group
from loss of mono-MeO-Fuc residue. It was noteworthy that the specific
position of this mono-methoxyl group in the terminal Fucose was not defined
due to the lack of diagnostic ions. Thus, the antenna sequence of glycan 3
was defined as mono-0-methyl-Fuc(1-2)-4-Omethyl-GlcA(1-4)
[GlcNAc(1-3)]Fuc(1-4)GlcNAc. The branching information of glycan 3 was
also obtained by exploiting (-) MSn spectra on native glycan (See Appendix
for Spectra), which showed the same branching pattern as glycan 1.
Therefore, glycan 3 was characterized as shown in Figure 2.11.

46

2.4 Discussion
New Overall MS-based Strategy
As demonstrated above, this new mass spectrometry-based strategy
provided the opportunity to characterize the detail structure of A/-glycans from
the EP glycoprotein, except for the anomericity. Theoretically, the anomericity
may be obtained through MSn FragLib comparisons [Hanneman 2006;
Ashline 2005], such as identification of Gal/?(1-4)Fuc modification on C.
elegan core GlcNAc via synthesized samples [Hanneman 2006], but the
availability of these pure state standard carbohydrate moieties were always
limited. Accurate mass measurement was obtained on a common LTQ
instrument using ultrazoom scan rather than the expensive LTQ-Orbitrap or
LTQ-FTICR. The methylated derivates of monosaccharides were used to
perform GC/MS experiments, which were allowed to identify GIcA residue
with natural methoxyl modification.
Although (-) MS/MS potential use on A/-glycan structural process has
been summarized recently [Harvey 2008; Harvey 2005c], and has been
employed to identify many biological glycans [Harvey 2009b]. But this is the
first time to employ negative ion MS" (not MS/MS) to define the exact
antenna location using distinguishing E ion [Harvey 2005c], which retains
both C-2 and C-4 linkages of the branching mannose (Man-3 or Man-6).
Since the D ion consisting of the Man-6 arm portion could be obtained
specifically, further disassembly of the D ion may reveal the antennae
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locations of Man-6 arm. Because the E ion was not found from the Man-6
arm of D ion pathway in glycan 1, the two antennae most probably
connected to C-2 and C-6 of Man-6 rather than C-2 and C-4 as seen in
Man-3 arm. The biological significance of the specific antenna location
information has never been appreciated due to the lack of a general method
to reveal this exact structural information. Since (-) MSn could be used on
either acidic glycans or neutral glycans with anionic ions adduct [Harvey
2008], this strategy appeared providing a general method to define the
branching pattern of A/-glycans. Furthermore it was believed that Fuc-3
modification on the innermost core GlcNAc will inhibit PNGase F to release
A/-glycan from the protein backbone, negative ion MSn on native A/-glycan
provide a convenient and direct analytical method to differentiate Fuc-3 and
Fuc-6 attachments (Figure 2.8). This technique may be particularly valuable
when both of Fuc-3 and Fuc-6 modifications are present on the A/-glycan core
structure [Varki 1999] or even unusual modification on core structure
[Hanneman 2006].
Proposed Mechanisms to Interpret the Fragment Ions
Several mechanisms were proposed to interpret the prominent
fragmentation ions in the spectra. In scheme 2.1, a distinguishing daughter
ion m/z 920.5 came from the CD3 labeled antenna B ion m/z 952.6 (figure
2.4). This 32 Da neutral loss not only confirmed the presence of a natural
methoxyl group in the antenna but also indicated its labile property under
48

positive ion CID fragmentation pathway due to the presences of many
deuterated methoxyl groups. Because the neutral loss of terminal mono-GIcA
moiety [M-190] has been observed in negative ion MSn spectra, and the
presence of GIcA was confirmed by GC/MS, it will be readily deduced that the
natural methoxyl group must be located on the C-4 of the GIcA, thus it can
easily be explained that the elimination of C-4 methoxyl group will form a
conjugated double bond with the carboxylic group on C-6 in GIcA, which is
extraordinarily favored due to the low energy of the product comparing to
CD3OH loss (m/z 917.5, figure 2.4). In addition, the presence of this
conjugated intermediate is further confirmed by following disassembly of that
ion m/z 920.5 (figure 2.4 inset), an abundant fragment ion m/z 770.5 was
obtained after a neutral loss of 150 Da. That fragment ion m/z 770.5 can be
rationalized via a retro Diels-Alder mechanism (Scheme 2.1). It will be worthy
to point out that retro Diels-Alder fragmentation are the most abundant and
common cross-ring cleavage ions in CID MSn spectra on carbohydrate
[Ashline 2005], which is diagnostic for most inter-residue linkage. During
this case, deuterated methylated derivatives can provide particular
information to identify natural methoxyl group position under positive ion MSn
disassembly.
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Scheme 2.4. Commonly neutral loss of 42 Da from HexNAc 1,2-ene
parent ion due to sigmatropic [1.5] hydrogen rearrangement
fragmentation

In schemes 2.2 and 2.3, sigmatropic [1.7] and [1.5] hydrogen
rearrangement are proposed to explain the formation of ions m/z 665.4
(figure 2.5a) and m/z378.2 (figure 2.5b), respectively. Although little was
known how the sodium cations are involved in these fragmentation pathways,
considering the abundance of these daughter ions, it may be speculated that
sodium cation will decrease the activation energy compared to the normal
thermal sigmatropic rearrangements. Moreover, [1.5] sigmatropic hydrogen
rearrangement have been widely observed in many standard
oligosaccharides fragmentation, even if systematic investigation on these
mechanisms has never been reported. A better known example is the
common 42 Da neutral loss from HexNAc moiety (Scheme 2.4). [1.7]
sigmatropic hydrogen rearrangement is less common but also observed on
pyronaridine's fragmentation in positive mode low-energy CID ion trap mass
spectrometry [Lee 2004].
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Structural Features of these Novel A/-qlycans
The most obvious structural features of the EP A/-glycans are both
novel antenna sequences: 4-0-methyl-GlcA(1-4)[GlcNAc(1-3)]
Fuc(1-4)GlcNAc and mono-0-methyl-Fuc(1-2)-4-0-methyl-GlcA
(1-4)[GlcNAc(1-3)]Fuc(1-4)GlcNAc, which have never been reported
previously. A similar tetrasaccharides moiety was found in a minor
glycospingolipid 4-0-methyl-GlcA(y#1 -4)[3-0-methyl-GalNAc(or1 -3)]
Fuc(a1 -4)GlcNAc(y#1 -2)Man(a1 -3)[Xyl(^1 -2)]Man(£1 -4)Glcy91 -ceramide
isolated from the spermatozoa of fresh water bivalve, hyriopsis schlegelii
[Scarsdale 1986; Hori 1983], suggesting the presence of a unique glycan
biosynthetic pathway leading to the branching fucosylation in the bivalve
class. This notion was also supported by a recent report in which internal
fucose branching in A/-glycan antenna was found in the hemocyanin of
Rapana thomasiana [Gielens 2005; Idakieva 2004]. The antenna sequence
of Rapana thomasiana was also a tetrasaccharides moiety starting from the
non-reducing end: 3-0-Methyl-Gal-[GalNAc]-Fuc-GlcNAc, which was similar
to the antenna sequence of the major glycan 1. Fucosylation is commonly
regarded as a terminal modification like sialic acid, which will prevent any
further extension to the sugar chain, like a "Cap" [Varki 1999]. Since no other
internal fucosylation has been reported so far according to our knowledge, it
is not clear whether this is a unique glycosylation pattern in the bivalve class,
or not. The key point is that these cases demonstrate the complexity of
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natural glycosylation, which are not always synthesized under strict
regulation according to the known glycosylation pathway. Therefore, a mass
spectrometry-based de novo strategy is indeed needed to define glycan
structures, especially for those less-studied organisms.
Another structural feature of EP glycans is its naturally occurred
methoxyl modification. Natural methoxyl modification has been found widely
present in many low-level animals [Gutternigg 2004; Puanglarp 1995; Khoo
1991; Hall 1977]. Unfortunately, the biological functions of these natural
methoxyl modifications have not been fully understood so far. Since methoxyl
group is modified usually on the non-reducing end terminal residues (GIcA
and Fuc), it may suggest this modification may be well-controlled for its
biological functions, such as signal transformation, receptor recognition, etc.
Implications for Its Metal Ion binding Ability
The fascinating property of the EP protein is its strong affinity with
many metal ions [Hattan 2001]. It is evident to deduce these multiple
antennary A/-glycans have metal ions binding ability due to its flexible arms
and terminal glucuronic acid residues. Since the majority of /V-glycans
contains 4- or 5 antennae in EP glycoprotein, it also suggests that the binding
of the metal ions may need cooperation of two or three antennae, and
functions as a chelation agent. According to these identified N-glycan
structures, the EP glycoprotein can keep the metal ion binding ability even if it
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was denatured since its A/-glycans may take part in metal ion binding directly
[Nair1999].
Summary
In a word, we have characterized novel A/-glycosylation structures
from EP glycoproteins isolated from mollusk: Mytilus edulis via a new mass
spectrometry strategy in which combined accurate mass measurement,
GC/MS, chemical modification, positive ion MSn, and negative ion MSn
techniques. The unique antenna sequence, 4-0-methyl-GlcA(1-4)
[GlcNAc(1-3)] Fuc(1-4)GlcNAc, and multiple antennae may provide the
structural basis of its binding ability to various metal ions.
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CHAPTER 3
A/-Glycosylation Analysis of Neuraminidase
from the 1918 Pandemic Influenza Virus H1N1

3.1 Introduction

Introduction to Influenza Virus
Influenza viruses are highly contagious and may cause severe
respiratory illness and death in humans. There are three viral genera within
the influenza family: A, B and C, distinguished on the basis of their antigenic
differences between their matrix proteins and nucleoproteins [Lamb 2001;
Wright 2001]. Influenza A, B and C viruses also differ with respect to host
range, variability of surface glycoproteins, genome organization, and
morphology [Lamb 2001]. Of the three types of influenza virus, type A infects
a wide range of avian and mammalian species and is responsible for all
major pandemic outbreaks of influenza, and for most of the well-known
annual "flu" epidemics [Wright 2001]. Both influenza B and C also infect
humans but only lead to mild common-cold-like symptoms [Wright 2001] and
recovery may be expected in a few days without any medical treatment.
Therefore, influenza A virus is the primary research focus, and gains the
most clinical concern.
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Influenza A virus can be further classified into subtypes according to
the serological reactivity of its surface glycoprotein antigens: hemagglutinin
(HA) and neuraminidase (NA) [Lamb 2001]. Currently, sixteen subtypes of
HA (H1 to H16) and nine of NA (N1 to N9) have been identified in avian and
mammals species (WHO, Table 3.1). All subtypes have been found in avian
species, routine tests of wild birds always find some influenza A viruses
present, especially in migrating aquatic wild birds. It is believed that all
influenza viruses originated from avian species, which are usually referred as
"avian influenza". The aquatic birds serve as a reservoir for all influenza A
viruses, providing the likelihood of trans-infection to domestic birds [Hinshaw
1980], and mammals. Surprisingly, the vast majority of these viruses are
harmless to their wild hosts. Only limited subtypes have been identified in
human and other mammals (Table 3.1). As for human influenza viruses, the
subtypes that account for the three pandemics of the last century were the
1918 H1N1 "Spanish flu"; the 1957 H2N2 "Asian flu"; and the 1968 H3N2
"Hong Kong flu" [Wilschut 2005]. Several other influenza subtypes: H5N1,
H7N7 and H9N2, have also been reported to infect human sporadically since
1997 and cause high death rate [World Health Organization Website]. Since
these viruses have not been transmitted in the human population and do not
carry the human viruses' characteristics, they are generally regarding as
avian viruses rather than human viruses. Besides human, the influenza virus

55

also infects many other mammals such as: pigs, horses, seals, whales, etc.
(Table 3.1) [Wilschut 2005; Lamb 2001].
The current nomenclature system for the influenza A virus include the
host of origin, geographic locations of the first isolation, strain number and
year of isolation [WHO memorandum 1980]. The HA and NA subtypes are
usually specified in parentheses, such as: A/Swine/lowa/15/30 (H1N1). By
convention, the host origin of human strains is omitted, such as:
A/Vietnam/1203/04 (H5N1), and A/Puerto Rico/8/34 (H1N1).

Major Structural Components of Influenza A Virus
The influenza virus has a roughly spherical shape, and its size ranges
between 80-120nm in diameter. The capsid is surrounded by a lipid envelope,
from which projects two major surface glycoproteins, HA and NA. Within the
capsid resides the genome which is divided into eight ribonucleoprotein (RNP)
segments. The genetic material is a single strain (-) sense RNA
(complementary to mRNA) and associated with three polymerase
polypeptides [Duesberg 1969]. Figure 3.1 is a model of the overall structure
of influenza virus. The virus has approximate 500 spike-like projections on
the surface. These represent the distinguished HA (cone shape) and NA
(mushroom shape) glycoproteins [Wright 2001; Steinhauer 1998; Colman
1998].
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Table 3.1. Natural hosts of influenza A viruses (adapter from Wilschut
2005)
Haemagglutinin

Neuraminidase

Designation

Predominant Hosts

Designation

Predominant Hosts

H1

Human, pig, birds

N1

Human, pig, birds

H2

Human, pig, birds

N2

Human, pig, birds

H3

Human, pig, birds, horse

N3

Birds

H4

Birds

N4

Birds

H5

Birds, (human)

N5

Birds

H6

Birds

N6

Birds

H7

Birds, horse, (human)

N7

Birds, horse

H8

Birds

N8

Birds, horse

H9

Birds, (human)

N9

Birds

H10

Birds

H11

Birds

H12

Birds

H13

Birds

H14

Birds

H15

Birds

H16

Birds
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Ion channel

Haemagglutinin

RNP

Neuraminidase
(Sialidase)
Lipid envelope

Figure 3.1. Typical influenza virus structural model (adapted from Lamb
2001)
Haemagglutinin (HA) is the major envelope glycoprotein, usually four
times abundant than neuraminidase (NA). The primary function of HA is to
recognize and attach onto the glycoconjugates that terminate with a sialic
acid residue. Such structures are components of glycoproteins and
glycolipids embedded in the host cell surface, and appear to be the essential
step for the viral entry and infection [Gamblin 2004; Colman 1998]. It is
believed that the major difference between avian virus and human virus is
their HA binding specificity. Generally human virus recognizes sialic acid a
(2,6) galactose residue [SAor(2,6)Gal], which are believed to be dominant in
the human respiratory track epithelium cells; whereas avian influenza virus
prefer SA or (2,3) Gal residue, an abundant epitope on the surface of the
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avian intestinal tract [Yamada 2006; Stevens 2006a; Stevens 2006b; Weis
1988].
HA is synthesized in the endoplasmic reticulum as a single
polypeptide chain (HAO, approximately 560 amino acids). The mature HA is
assembled as a trimer consisting of three identical monomers before being
exported to the host cell surface. On the cell surface, HAO is cleaved by
trypsin-like proteases secreted by the host cell into two disulphide bond
connected subunits, HA1 and HA2. This host specific digestion is essential
for HA to mediate membrane fusion to the host cell [Skehel 2000; Bullough
1994; Kim Carr 1993; Wilson 1981]. For this reason, most human influenza A
viruses are limited to infect the human respiratory tract where there is a
distribution of relevant proteolytic enzymes [Steinhauer 1999; Klenk 1994].
As for the high pathogenic avian influenza viruses, such as H5N1 and H7N2,
their HAs can be cleaved by intercellular proteases, in a process that occurs
just before HAO reaches the cell surface of the infect host cell, due to the
presence of multiple basic amino acids located at the cleavage site in these
HAs [Kawaoka 1988; Webster 1987]. Because these proteases are
ubiquitous in all cell types, viruses with HA containing these multiple basic
amino acids in the cleavage site could easily spread throughout the body,
and usually lead to a fatal systemic infection.
Another surface glycoprotein of virus is NA, a mushroom-shape
tetrameric glycoprotein (Figure 3.1). Each monomer usually contains around
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450-500 amino acid residues depending on the individual virus strain, and is
subjected to oligomerize before reaching the host cell surface. All nine
subtypes of NA are tetrameric and share a common structure consisting of a
globular head, a thin stalk region, and a small hydrophobic region that
anchors the proteins in the virus membrane (Figure 3.1) [Colman 1998]. The
principal biological function of NA is to catalyze the cleavage of the terminal
sialic acid residue from various glycocojugates such as glycoproteins and
glycolipids on the host cell surface, which are virus HA binding receptors. NA
is important during the final stages of influenza virus infection because it
removes the sialic acid from infected cell surfaces which are attached by
newly formed virions, thus facilitating progeny viruses release and spread of
the infection to the neighboring cells [Bucher 1975; Palese 1974]. The active
site of NA consists of a pocket on the surface of each subunit formed by
fifteen charged amino acids. These amino acids are highly conserved in all
viruses [Colman 1983; Varghese 1983], which makes NA the perfect target
for the antiviral drug [Itzstein 1993]. Two current anti-flu drugs oseltamivir
(Tamiflu) and zanamivir (Relenza) are transitional state analogues of sialic
acid-galactose, which efficiently inhibit the enzymatic activity of NA, thus
preventing the spread of infection. Furthermore NA may also contribute to the
removal of the decoy sialic acid receptors on mucins, cilia, and the cellular
glycocalyx in the human airway, which will promote the penetration of the
virus through the ciliated epithelium cells [Matrosovich 2004a].
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The virus envelop also contains a small number of copies of integral
membrane protein, M2, which forms a tetramer with ion channel activity
[Zebedee 1988; Lamb 1985]. M2 is believed to modulate the pH within virions,
weakening the interaction between the viral ribonucleoproteins (RNPs) and
M1 protein. M2 is the target for the anti-influenza drugs amantadine and
rimantadine [Hay 1992].
The viral core contains eight strands of negative-sense single
stranded RNA [Lamb 2001]. Each RNA segment is connected with multiple
copies of nucleoproteins (NP), and with the viral transcriptase consisting of
RNA polymerase components PB1, PB2 and PA, thus forming the
ribonucleoproteins (RNP) complex. The RNPs are surrounded by a layer of
the matrix protein: M1. M1 is the most abundant structural protein within the
virus, approximately 3000 copies per virion [Lamb 2001].
Because of its simple biological structure, the influenza virus is
constantly evolving by two mechanisms: antigenic drift and antigenic shift
[Bouvier 2008; Shoham 2006]. Antigenic drift is induced by the selection
pressure of the host immune system which accounts for the most annual
epidemics. Antigenic drift occurs as a result of continuous mutation of the
RNA genome of the virus because of the errors made during the RNA
replication process. Therefore, amino acid changes in the viral proteins arise,
including substitutions in the antigenic area of HA and NA. Virus variants with
a selective advantage are remained by the pre-existing immunity of the host.
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Another pathway to form new viruses is "antigenic shift" also called as
"reassortment", which occurs in the same host infected by two or more
different types of influenza viruses at the same time. New viruses may
emerge by exchanging some portion of their RNA fragments with others,
which accounted for the pandemic influenza outbreaks in 1957 and 1968
[Kawaoka 1989; Scholtissek 1978]. Since pigs can be infected by both avian
and human viruses, they have been considered as "transmission vessels"
between avian and human species for a long time [Ludwig 1995; Scholtissek
1994]. Currently high pathogenic avian H5N1 and H7N7 viruses have been
reported to infect humans directly without any intermediate vessel. This
emphasizes the possibility that new pandemic virus strain could emerge
because the reassortment can take place directly in human. Fortunately,
these high pathogenic avian viruses have not obtained the capability for
efficient human-to-human transmission. It was believed that avian virus could
not infect the human upper respiratory tract due to the lack of appropriate
SA-Gal epitope, which will be discussed in detail in Chapter 4.
The Unique 1918 Influenza Virus (H1N1) "Spanish Flu"
The 1918 influenza "Spanish Flu" was the most devastating pandemic
of any infectious disease in the recorded history. It spread globally, and
infected almost 25 to 30% of the world's population. It was estimated that
"Spanish Flu" killed approximately 40 million people worldwide, including
more than 600,000 deaths in the United States. In contrast, both 1957 "Asian
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flu" (H2N2) and 1968 "Hong Kong flu" (H3N2) were less severe and caused
less than 80,000 deaths for each pandemic in the United States [Wilschut
2005]. Unlike the 1957 and 1968 viruses, the causative agent of the 1918
pandemic was not known at that time, and no original 1918 virus samples
were kept intact. Our understanding to this virus has relied on the historical
accounts and the clues from the current viruses. Fortunately Dr.
Taubenberger and his co-workers have been able to obtain all eight segment
RNA sequences of the 1918 virus from an Alaskan Inuit woman who was
interred in permafrost in Brevig Mission, Alaska. Thus the strain of this virus
was designed as A/Brevig Mission/1/18 (H1N1) [Reid 2002; Basler2001;
Reid 2000; Reid 1999; Taubenberger 1997], and has provided the
opportunity to research this notorious virus for the first time and further
improve our understanding to this pandemic. Such studies may help us to
prepare for any potential influenza pandemics in the future, such as current
Mexico H1N1 flu.
Besides its severity, the 1918 influenza flu had several unique features,
distinguishing it from other pandemic and epidemic viruses. The first was its
mysterious origin. Prior to 1918, no highly virulent viruses were recorded to
circulate in humans. It appeared that this virus suddenly emerged from
several locations in the world mysteriously [Taubenberger 2006]. According
to phylogenetic analyses of its HA and NA sequence, this virus most likely
originated from an avian species, but may have circulated in humans for a
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short time before the pandemic [Reid 1999; Reid 2000]. Thus, it kept most of
the avian characteristics but acquired enough changes to spread and
replicate efficiently in humans. This notion was indeed supported by recent
HA glycoarray binding experiments: its HA can bind both SA-Gal a (2,3) and
or (2,6) epitopes [Stevens 2006b; Gamblin 2004].
The second feature of the 1918 virus is its exceptional virulence.
Unfortunately neither 1918 HA nor 1918 NA genes has obvious genetic
characteristic that can account for such virulence [Taubenberger 2006].
Recent highly-pathologic H5 and H7 viruses have been found able to cause
systemic infection due to the presence of multiple basic amino acid sites for
HA1 and HA2 cleavage, which could be activated by ubiquitous proteases in
cell [Kawaoka 1988; Webster 1987]. However, this kind of feature hasn't
been observed in the 1918 HA sequence [Reid 1999]. Another genetic
mutation has been reported in the NA sequence (N146R or N146Y, leading
to the loss of a glycosylation site), appearing to allow the virus to replicate in
many tissues beyond the respiratory tract in a mouse model [Li 1993].
However, this mutation was not found in the 1918 NA sequence [Reid 2000].
This information is in agreement with the historical medical records that
reported the 1918 virus didn't replicate outside of the respiratory system
[Taubenberger 2006]. Thus, the factors relating to its far-reaching virulence
of the 1918 virus has caught the attention of many virologists.
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Another fascinating feature of 1918 virus is its high mortality rate
among young adult populations, especially for the age group (25-34), who
are usually not effected seriously by common influenza viruses. As shown in
Figure 3.2, the age group (25-34) showed a dramatic high death rate
comparing to other age groups: (5-14) and (44-54). An explanation for this
has been proposed that there may have some sort of precursor of thel 918
H1N1 viruses circulating before 1889 providing the limited immunity.
Therefore, people born before 1889 may have had partial immunologic
protection [Taubenberger 2006]. This theory may partially explain the high
morbidity rate in young age groups, but certainly it does not address why the
age group (25-34) has a higher death rate than the age group (5-14) because
both groups were immunologic naive to the virus. It could be speculated that
there must have some unique biological features associated with age group
(25-34) to facilitate the virus infection.
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Figure 3. 2. Influenza and pneumonia mortality by age (solid line), with
influenza morbidity by age (dash line) superimposed. Specific death rate
per age group, left ordinal axis. Influenza morbidity presented as ratio of
incidence in persons of each group to incidence in persons of all ages (= 100),
right ordinal axis. [Adapter from Taubenberger 2006].

3.2 Research Background and Purpose

The Neuraminidase of the 1918 Virus and its Glycosylatiort
Influenza virus NA is the second most abundant surface glycoprotein
and essential for the virus infection. As discussed above, the primary function
of NA is to hydrolyze the terminal sialic acid residue from the host cell surface,
thus enabling the progeny viruses to spread and infect other cells and tissues
[Colman 1998]. Furthermore, NA is also the major antigenic component
besides HA. Host immunologic selection drives the constant change of the
NA sequence [Johansson 2007]. Therefore, an investigation of NA structure
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is one of the key steps to understand influenza virus infection. As for 1918
influenza virus, it has been demonstrated that HA, NA and PB1 are related to
its exceptional virulence by single gene reassortants experiments [Pappas
2008].
The 1918 NA sequence has been successfully recovered from an
Alaska woman (A/Brevig Mission/1/18, H1N1) [Reid 2000]. The 1918 NA
contains 469 amino acid residues and 7 potential /V-glycosylation sites:
Asn50, Asn58, Asn63, Asn68, Asn88, Asn146, and Asn234 (Figure 3.3). The
active NA protein is configured as a homotetramer containing a large
box-shape globular head, a thin stalk region, and a short hydrophobic tail
buried in the virus membrane [Xu 20008]. The active site is located on the
membrane-distal surface of the globular head, close to the pseudo axis
through the center of each monomer, which is very well conserved in all
subtypes of NA [Xu 2008]. Three potential A/-glycosylation sites are in the
ectodomain of NA: Asn88, Asn146, and Asn234. Both Asn88 and Asn234 are
located on the inner surface of the molecule, whereas Asn146 is on the
membrane-distal face, close to the active site [Xu 2008]. Asn146 is highly
conserved in all N1 subtype NA including both avian and human viruses. It
was found that mutation of this A/-glycosylation site may lead to influenza
virus spreading to the other organs in the mouse model, which is associated
with virus's virulence [Li 1993]. But it is not sure whether this is the case in
other hosts systems.
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The stalk region is usually made up of approximately 50 amino acid
residues starting from the 40th amino acid counting from the N terminus of NA.
The stalk region of 1918 NA has one cysteine (Cys49) and four potential
A/-glycosylation sites (Asn50, Asn58, Asn63, and Asn68). It was found that
under selection pressure, HA may acquire new /V-glycosylation sites (up to 7
extra sites) in human strains [Matrosovich 1999; Inkster 1993; Deshpande
1987], which is believed to benefit the viruses masking the antigenic area.
Unlike HA, the four glycosylation sites in the stalk region of NA are highly
conserved in all H1N1 viruses regardless of human or avian strains (the
exact sites may vary by strains), implicating some important functions which
are not clear currently.
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1918 NA amino acid sequence
1

mnpnqkiiti gsicmwgii slilqignii siwvshsiqt gnqnhpetcn
51

<jsaitye«nt wvngtyvni* n t n w a g q d a zsvllzgnss
101
skdngirigs
151
drspyrtlms
201
gavavlkyng
251
asykilkiek
301
rpwvsfdqnl
351
Frydngvwig
401
gysgsfvqhp
451
dtvgwswpdg

lcpisgwaiy

kgdvfvirep fiscshlecr tffltqgall ndkhsiifftvk
cpvgeapspy nsrfesvaws asachdgmgijj ltigisgpdn
iitdtikswr nnilrtqese cacvngsrcft imtdgpsngq
gkvtksieln apnyhyeecs cypdtgkvmc vcrdnwhgsn
dyqigyicsg vfgdnprpnd gtgscgpvss ngangikgfs
rtkstssrsg femiwdpngw tetdssfsvr qdivaitdws
eltgldcmrp cfwvelirgq pkentiwtsg ssisfcgvns
aelpfsidk

Tryptic peptide stalk region:
I I T I G S I C H W G I I S L I L Q I G N I I S IWSHSIQTGNQWHPETCNQSIITYENNTWNQT
YVNJSNTNWAGQDATSVILTGNSSLCPISGUAIYSK

Figure 3.3. The complete amino acid sequence of 1918 NA is listed in the top
panel. It contains 469 AA residues and seven potential A/-glycosylation sites
highlighted as red. The stalk region of the tryptic large peptides includes five
potential A/-glycosylation sites and is listed in the bottom panel.

Recently 1918 tetrameric NA protein was reported to have different
glycosylation pattern compared to the corresponding monomer and dimer
forms [Wu 2009]. In brief, 1918 NA DNA sequence was chemically
synthesized and inserted into a baculovirus genome system. Subsequently
the recombinant virus was grown in the Sf21 insect cell line, and the crude
NA proteins was harvested and purified. Interestingly the active tetrameric
NA only accounts for 10-15% of total product NA and the rest is the inactive
monomer and dimer forms (Figure 3.4). It was found that tetrameric NA has a
stable structure and will not disassociate into monomer and dimer, whereas
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the dimer and monomer NA can mutually convert to each other in the solution
but not tetramer (Figure 3. 4). Further analysis has shown that the tetrameric
NA may have a distinct A/-glycosylation pattern compared to other forms.
Interestingly de-A/-glycosylation of tetramer will not affect NA enzyme activity;
suggesting A/-glycosylations is not close to the NA active site, and not
essential for keeping the tetrameric three-dimensional structure. Therefore, it
can be concluded that A/-glycosylation is involved in the formation of the
active NA tetrameric structure. And once the mature tetramer has been
formed, it will be able to keep a relatively stabilized shape resistant to
proteolytic digestion under native condition. Given the insect cell lines are
known to produce some simple high mannose A/-glycans, which may be
different with the human cells glycans [Kost 2005]. A systematic analysis of
A/-glycans from various oligomer of NA will be the key to understand the
difference between the active NA and the inactive NA. The specific purposes
of this project are defined as following:
•

Detail /V-glycan structural analyses of dimer and tetramer NAs by
mass spectrometry, especially MSn

•

Comparison of /V-glycan structures between dimer and tetramer NAs
and identify the difference, especially those located in the stalk region

•

According to the difference, find the connection to the real virus host
systems such as human cells.
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Figure 3.4. The expressed 1918 NA exists in three forms: tetramer (t),
dimer (d), and monomer (m). Chromatography of these NA forms was
separated on a superdex-200 gel filtration column (top panel).
Re-chromatography of the separated forms after 2 weeks storage in the
solution (lower panel), showed no inter-conversion between tetramer with
dimer/ monomer [Adapted from Wu 2009].

3.3 Experimental Procedure

Materials and Reagents
Purified dimer and tetramer NA was provided by Dr. Wu (R&D System
Inc. Minneapolis, MN 55413). Procedures to obtain these materials were
described in the reference [Wu 2009]. The glycerol-free PNGase F and
associated reagents (10 x denaturing buffer, NP-40, G7 buffer) were
purchased from New England Biolabs (Beverly, MA). Proteomic grade trypsin
(25 jig per vial), dimethyl sulfoxide, sodium hydroxide, iodomethane, sodium
borohydride, sodium borodeuteride, dithiothreitol, Urea, iodoacetamide,
trifluoroacetic acid, tetrahydrofuran, toluene and ethanol were obtained from
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Sigma-Aldrich (St. Louis, MO). 7000 MWCO membrane dialysis cassette was
purchased from Pierce (Prod# 66370, Rockfold, IL). 10, 000 MWCO
microcon centrifugal devices were obtained from Millipore (Ultracel YM-10,
Bedford, MA).
Procedure of Trypsin Digestion
NA proteins samples (dimer and tetramer) were received in a buffer
solution (20 mM Tris and 0.15 M NaCI). The salts were removed by
membrane dialysis against 5 mM NH4HCO3/0.01% SDS overnight using
7000 MWCO (Pierce, Rockfold, IL). The protein solution was transferred to a
1.5 mL Eppendorf vial and dried under vacuum. The dried proteins were
dissolved in 50 \xL 8M urea / 0.4M NH4HC03 and reduced by the addition of 5
|iL of 45 mM DTT (dithiothreitol) and incubated at 50°C for 45 mins. The
protein was subsequently alkylated with freshly prepared 2 uL of 100 mM IAA
(iodoacetamide) at room temperature for 30 mins. The trypsin was activated
by 1 mM HCI solution and added into the reaction solution at weight ratio
(1/25: trypsin/protein). The reaction solution was adjusted to a final
concentration of 2M urea/0.1 M NH4HC03 and incubated at 37 °C overnight
(11 -15 hours). The reaction was stopped by addition of several drops of
trifluoroacetic acid in an ice bath and then dried under vacuum. The salts
were removed by passage through a Ci8-SPE cartridge (Strata-X 33um
30mg/ML, Phenomenex, Torrance, CA) with 2% ACN/H20 containing 0.1%
TFA. The digested peptides were eluted with 70% ACN/H20 containing 0.1%
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TFA. In selected cases the stalk region glycopeptide was separated with
other low molecular weight mixture by dialysis against 10, 000 MWCO
centrifugal device (Millipore, Bedford, MA). Briefly, the tryptic peptides
mixture was diluted to 500 u.L water solution and applied onto the 10, 000
centrifugal device. The rotor speed was set at 11, 000 r/minutes as
recommended and centrifuged for 25 mins. The membrane retention fraction
was collected and subjected to de-glycosylation procedure.

/V-qlvcan Release by PNGase F
The total tryptic peptide mixtures, (or the stalk region peptide), were
dried and re-dissolved in 5 uL stock 10X G7 buffer (500 mM sodium
phosphate) and 45 u.L H 2 0. To this was added 1 u.L of PNGase F stock
solution and incubated at 37 °C overnight. The free A/-glycans were
separated from peptides by a hand-packed graphitized carbon cartridge
(Alltech, Deerfield, IL). The graphitized cartridge was pre-washed thoroughly
with water, and the reaction mixture applied. The buffer and salt were
washed through with excess H 2 0, and the glycans were eluted with 5-6
volumes of 25% ACN/H 2 0 containing 0.1% TFA.

Reduction and Permethvlation of AA-qlvcans
The eluted glycans were dried and reduced by the addition of 200 juL
sodium borohydride solution (10 mg/mL in 0.01 M NaOH) and allowed to
stand at room temperature overnight. The reaction was quenched by the
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addition of several drops of acetic acid in the ice bath, followed by addition of
3 ml_ pure ethanol, and dried under vacuum. Excess borate was removed as
its methyl ester by the repeated addition of 3 ml_ 1% acetic acid in methanol
and drying under vacuum until all residue salts were gone. This is followed by
the addition of 3 mL toluene and drying under N2 gas, repeating twice. Then
the glycans were further desalted either by passage through a cation
exchange resin (Dowex 50w, Sigma, St. Louis, MO) or graphitized cartridge.
The dried glycan sample was dissolved in 300 uL DMSO in a glass
tube, following a small amount ground NaOH powder and vortexing for 5
mins. lodomethane (50 uL) was then introduced into the tube, followed by
vortexing for 40-50 mins, to form a white cloudy suspension solution. The
reaction was stopped by the addition of 1 mL dichloromethane and 1 mL of
5% acetic acid, sequentially, in ice bath. The methylated glycans were
isolated by liquid-liquid (H20/CH2CI2) extraction, repeated 3 times. The
combined organic layers were then back washed 5-6 times with water. The
dichloromethane was evaporated under N2 gas and ready for mass
spectrometry analysis.
Radioactivity of Fuc Incorporation onto Dimer and Tetramer in Vitro
1 ug of substrate (dimer or tetramer NA) was mixed with 2 ui of
GDP-3H fucose (1.2 uM from Perkin Elmer), 0.5 ja.g of recombinant FUT8,
and diluted with buffer (10 mM Tris, 10 mM MnCI2, pH 7.0) to a total of 20 |il.
This solution was incubated at room temperature for 10 minutes. The
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incorporation of 3H fucose onto the dimer and tetramer neuraminidase was
then measured using a filter binding assay.
Filter Binding Assay
After 3H-fucose incorporation with FUT8, 8 \i\ reaction sample from
each reaction was spotted on to glass microfiber filter (Cat# 09-874-34;
Fisher Scientific, Kansas City, MO). To this a drop of 75% ethanol was added
to cover and denature the protein. The filters were dried and then thoroughly
washed in 200 ml of water in a shaker for 5 minutes. Washing was repeated 3
times. The filters were countered with a LS 6500 scintillation counter in
Ready Protein ™ cocktail (Beckman Coulter, Fullerton, CA).

Tetramer NA Enzyme Activity Following In Vitro Fucosvlation
The NA enzyme was first diluted with a assay buffer (50 mM Tris, 5
mM CaCI2 and 200 mM NaCI at pH 7.5). To start the reaction, in a 96-well
fluorescent plate, 50 u.L of the diluted enzyme was added to 50 uL of 400 |iM
substrate 2'-(4-methylumbelliferyl)-a-D-N-acetylneuraminic acid
(4-MU-NANA, Sigma-Aldrich, St. Louis, MO). The reaction was monitored
with a fluorescence spectrometer at an excitation of 365 nm and emission of
445 nm in a kinetic mode. The detection was based on the fluorogenic nature
of the reaction product 4-methylumbelliferone, and the measurement
revealed a reaction velocity in terms of relative fluorescent units (RFU)
generated per unit time. To calculate the actual reaction velocity, a
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conversion factor between an RFU and the amount of product
4-methylumbelliferone (Sigma-Aldrich, St. Louis, MO) was determined in the
assay buffer.
Mass spectrometry
Native glycan MS profiles were performed on a MALDI-TOF
instrument (MALDI-CFR, Shimadazu, Kyoto, Japan). 1 u l matrix solution (10
mg DHB in 1 ml_ of 50% acetonitrile solution containing 0.1% TFA) was
applied on MALDI plate and air dried. Then 1 u.L sample solution was applied
to the well and mixed evenly with the matrix on the plate. When the solution
was dry, a drop of pure ethanol was applied onto the well and the sample and
matrix re-crystallized. MSn analyses were performed on methylated-reduced
glycans using an ESI-LTQ instrument (Thermo, Waltham, MA).

3.4 Results
MALDI-MS Profiles of Dimer and Tetramer /V-qlvcans
To enhance the release efficiency of PNGase F, both dimer and
tetramer NAs were subjected to trypsin digestion prior to de-glycosylation.
Aliquot of A/-glycans were reduced and per-methylated in preparation for the
MSn analyses [Ashline 2005]. MALDI-MS profiles of total native A/-glycans
from both forms were shown in Figure 3.5. Both forms have relatively simple
high mannose type glycoforms. The abundant peak in tetramer was m/z
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935.2, corresponding to the pentasaccharide core structure of the A/-glycan:
Man3GlcNAcGlcNAco/(Figure 3.5a). The following abundant peak was m/z
1081.4, had an identical composition with an additional fucose:
FucMan3GlcNAcGlcNAco/. All other peaks appear to be a series of low
abundant mannose type glycans, m/z773.3 (Man2GlcNAcGlcNAco/), 1097.6
(Man4GlcNAcGlcNAco/), 1259.7 (MansGlcNAcGlcNAco/), 1421.9
(Man6GlcNAcGlcNAco/), 1584.2 (Man7GlcNAcGlcNAco/), and 1746.5
(Man8GlcNAcGlcNAco/) (Figure 3.5a and 3.5c). No hybrid and complex type
A/-glycans were observed. In contrast to the tetramer, the most abundant
peak in the dimer profile was m/z 1081.4 (FucMan3GlcNAcGlcNAco/)
followed by m/z 935.3 (Man3GlcNAcGlcNAco/) (Figure 3.5b). Three other low
abundant fucosylated glycans were also present at m/z 919.2
(FucMan2GlcNAcGlcNAco/), m/z 1243.9 (FucMan4GlcNAcGlcNAco/), and
m/z 1284.8 (FucMan3GlcNAc2GlcNAco/) (Figures 3.5b and 3.5d), which was
absent in the tetramer. Furthermore, two low abundance high-mannose type
glycans Man7GlcNAcGlcNAco/and Man8GlcNAcGlcNAco/were present in
the tetramer form, but absent in the dimer.

Excess Fucosylated Glvcans in Dimer NA
The relative abundance ratio of each composition was calculated
according to their MALDI-MS peak intensities (Table 3.2) [Harvey 1999].
These calculations clearly showed that fucosylated structures account for
73.6% of total glycans in the dimer, compared to 18.1% in the tetramer. In
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order to ascertain the structural difference between both forms, a complete
structural analysis of all compositions was undertaken by ESI-MS" on
permethylated glycans.

Table 3.2. The relative ratio of each composition of both dimer and
tetramer NA were obtained from MALDI-MS spectra. (F: Fuc; H: Man; N:
GlcNAc). The ratio of fucosylated glycans are summed in the last row.
Native

Composition

(m/z)

Dimer

Tetramer

Relat. Ratio

Relat. Ratio
Tetramer (%)

Signal (I)

Signal (1)

Dimer (%)

773.3

H2N2

5.2

0.7

1.34%

1.35%

919.2

FH2N2

35

0

8.99%

0

935.3

H3N2

87

38

22.34%

73.22%

1081.4

FH3N2

249

9.4

63.94%

18.11%

1097.5

H4N2

8.9

0.3

2.29%

0.58%

1243.4

FH4N2

0.6

0

0.15%

0

1259.4

H5N2

1.2

1.3

0.31%

2.50%

1284.8

FH3N3

1.9

0

0.49%

0

1421.5

H6N2

0.6

1.5

0.15%

2.89%

1583.5

H7N2

0

0.5

0

0.96%

1745.6

H8N2

0

0.2

0

0.39%

73.6%

18.11%

I of Fuc

Detail Structural Analyses by Positive ion MS"
An aliquot of reduced A/-glycans from both forms were permethylated.
This derivative not only provides more structural detail upon collision induced
disassociation, but aides in sample purification and ionizes more efficiently
[Reinhold 1983]. Due to the complexity of the glycan structures, we will
majorly discuss only to two abundant compositions Man3GlcNAcGlcNAco/
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and Fuc Man3GlcNAcGlcNAco/shared by both forms, along with a uniquely
fucosylated structure in the dimerform (Fuc Man2GlcNAcGlcNAco/).

Structural Analysis of Composition of ManaGlcNAcGlcNAco/
The abundant ion in the tetramer NA with the composition
(Man3GlcNAcGlcNAco/) suggested it may be an A/-glycan core structure. This
was confirmed by MSn using the disassembling pathway, (MS5,
->1187.7->894.5->676.4^431.3; Figure 3.6a-d). The proposed
fragmentation ions that accounted for the major peaks were set adjacent to
each spectrum. MS/MS analysis of the molecular ion m/z 1187.7 provided an
abundant product ion at m/z 894.5 due to a neutral loss of the reducing end
GlcNAco/(A = 293, Figure 3.6a). Isolation and subsequent MS3 analysis of
this fragment, m/z 894.5, provided an abundant ion, m/z 676.4, indicating the
presence of a terminal mannose (A = 218), and also distinguished a
cross-ring cleavage fragment ion 3 5 A, m/z737.4 (A = 157). This ion and the
absence of a 0.4A-type fragment characterized a 1 -4 linkage between the
core mannose and the penultimate GlcNAc (Figure 3.6b). The MS 2 precursor
also fragments to provide a B- and C-type fragment (m/z 649.4, 667.4, Figure
3.6b) due to the neutral loss of the penultimate GlcNAc residue. Three
diagnostic fragment ions, m/z 301.1, 329.2 and 343.2 were present in MS5
spectrum (Figure 3.6d), confirming both Man-6 and Man-3 arms [Ashline
2005]. Therefore, the composition of Man3GlcNAcGlcNAco/was determined
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as an A/-glycan core structure. No other isomeric structures have been
detected in MSn spectra.
Structural Analysis of Composition of FucMaria GlcNAcGlcNAco/
MS2 analysis of the ion m/z 1361.7 (FucMan3GlcNAcGlcNAco/) from
the tetramer, provided a prominent B-type ion, m/z 894.4, and a minor neutral
loss ion at m/z490.3 (Figure 3.7a). These ions composition support a fucose
residue linked to the core reducing end GlcNAco/. The intervening linkages of
this disaccharide fragment, FucGlcNAco/, are known to be either at the 3- or
6-O-GlcNAc position, but the latter was indicated by the known specificity of
the enzyme, PNGase F. Importantly, the disassembling pathway following
the neutral loss, MS5: ^ 1 3 6 1 . 7 - > 8 9 4 . 5 H > 6 7 6 . 4 - > 4 3 1 . 2 (Figure 3.7b-3.7d),
proved to be identical to the pathway of the core structure
Man3GlcNAcGlcNAco/as discussed above (Figure 3.6b - 3.6d), indicating
structural similarity. The presence of three diagnostic fragment ions at m/z
301.1, 329.2, and 343.2, derived from a cross-ring cleavage of the core
mannose, confirmed the linkages on both the Man-3 and Man-6 arms.
Therefore, the structure was assigned as an A/-glycan core structure with an
extra fucose linked to the 6-O-position of the reducing end GlcNAco/ (N4-A,
table 3.3).
A small ion, (m/z 1068.5, arrow insert, A = 293, figure 3.7a), suggested
the presence of an isomeric structure without any fucosylated modification on
the reducing end GlcNAc. Further disassembly of m/z 1068.7 (Figure 3.8a),
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the fragment ions m/z 880.6 and 850.6 indicated the presence of fully
methylated terminal Fuc and Man residues, respectively. Following that
pathway (MS4: ->1361.7->1068.7->880.6), the abundant fragment ion m/z
676.4 (A = 204), derived from a neutral loss of internal hexose, indicated that
the terminal Fuc residue was attached to an internal hexose (Figure 3.8b),
most likely the core mannose. Another fragment ion m/z 662.4 (A = 218) also
confirmed the presence of the terminal hexose residue (Figure 3.8b). Further
disassembly of that fragment, m/z 431.2, provided a disaccharide doubly
scarred on the reducing terminus and a 6-O-linkage defined by the paired
ions at m/z 301.1 and 329.2. Two diagnostic ions at m/z 301.1 and 329.2 via
cross-cleavage fragmentation mechanism suggests that the terminal
mannose was located on 6-arm (Figure 3.8d). The lack of ion m/z 343.2
indicated the Fuc-Man disaccharide substitute on 3-arm most likely.
Unfortunately, the linkage between Fuc and Man was not possible to
characterize due to the low ion current. Therefore, this isomeric structure was
characterized as N4-B shown in table 3.3. No other isomeric structures have
been detected for this composition FucMan3GlcNAcGlcNAco/.

Structural Analysis of Composition FucMan?GlcNAcGlcNAco/
The profiled ion m/z 1157.7 provided a composition,
FucMan2GlcNAcGlcNAco/, which was unique in the dimer NA. MS2
disassembly of the molecular ion showed a prominent peak m/z 690.4
(Figure 3.9a), corresponding to the neutral loss of the reducing end of
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Fuc-GlcNAco/moiety (A = 467), indicated the terminal core fucosylation.
Assuming a core structure, the antennal positioned mannose moiety must be
either 3-, or 6-linked to the central core Man«(1-4)GlcNAc. Further loss of the
internal GlcNAc residue leaded to a dimer moiety at non-reducing end (MS4:
->1157.7->690.4->445.2; Figure 3.9c). Two cross-ring cleavage ions m/z
329.2 and 301.1 showed that the terminal residue is the branching 6-linked
mannose. The 3-linked mannose residue appears missing due to the
absence of the cross-ring cleavage fragment ion at m/z 343.2 such as seen in
other compositions. Thus the major isomeric structure of this composition
FucMan2GlcNAGIcNAco/was characterized as N2-A listed in table 3.3.
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There was a small peak showing a neutral loss of 293 Da (m/z 864.4,
Figure 3.9a), which indicated the absence of core fucosylation. Isolation of
this ion and further fragmentation provided two prominent product ions at m/z
676.4 (A = 188) and 472.3 (A = 188+204), indicating the presence of a
non-reducing terminal Fuc-Man moiety (Figure 3.10a and 3.10b). The
diagnostic ion at m/z 315.1 suggests this disaccharide moiety exclusively
locating at Man-6 arm (Figure 3.10b). Therefore this low abundant isomeric
structure was characterized as Fuc-Man(1-6)Man(1-4)GlcNAc(1-4)GlcNAc.
Another abundant ion m/z 646.3 (A = 218) in MS3 spectra of m/z 864.4
(Figure 3.10a) showed a neutral loss of 218 Da and suggested the presence
of a terminal Hex residue. This cannot be explained from the one proposed
structure and indeed it indicates the presence of another isomeric structure.
This terminal hexose residue was also detected in the subsequent MS 4
spectra of m/z 676.4 due to the presence of daughter ion m/z 458.2 (A = 218;
Figure 3.10b). The cross-ring cleavage ion at m/z 343.1 indicated the
terminal hexose was located on the Man-3 arm (Figure 3.10b). It also
suggested that the terminal fucose most likely was attached to C-6 of the
core mannose (Figure 3.10b) because an intact cleavage of the internal
GlcNAc was observed at ions m/z 419.2 (A = 227), and 401.2 (A = 245) in an
alternative MSn pathway (MS4: ->1157.7-^864.4-^646.4; Figure 3.10c).
Therefore, this isomer was proposed as N2-C (Table 3.3).
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All the compositions from both forms of NA were analyzed by MSn
method as discussed above except three large ions (Hex6GlcNAc2;
Hex7GlcNAc2; and Hex8GlcNAc2), which couldn't be analyzed due to the
weak signals. As for the compositions shared by both forms, no unique
isomeric structure has been found between them. All characterized structures
were proposed in table 3.3.
/V-qlvcans from the Stalk Region
The five A/-glycosylation sites (Asn55, Asn58, Asn63, Asn68, and
Asn88) were located in a single large tryptic peptide (Ile7 to Lys102) with the
size over 10K Da (Figure 3.3). The rest of the tryptic peptides were relatively
small, less than 6k Da making the stalk peptide easy to isolate from other
peptides via 10K MWCO membrane dialysis. An N-glycan differential
analysis of these stalk peptides were prepared and the native MS profiles
were obtained from MALDI-MS (Figure 3.11). The fucosylated ion (m/z
1079.4, FucMan3GlcNAc2) was the most abundant one and the core ion m/z
933.3, was around 50% abundant in the dimer NA (Figure 3.11 A). In contrast
to the dimer, the core ion m/z 933.3 was the most abundant peak in the
tetramer NA, and the fucosylated ion, m/z 1079.4, was barely visible (Figure
3.11b). The other smaller ions in the total glycan profile were not observed
from this fraction due to the low abundance.
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the spectra (a - c) as fellows: MS4^1157.7->864.4->676.4 and
MS4->1157.7->864.4->646.4. Fragments accounting for the spectrum are
proposed on the structure to the right as dotted lines. All ions are single
charged sodium (Na+) adducted ions.
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Table 3.3: The Characterized A/-glycan structures from dimer and
tetramer NA by MS" analysis. (H: Man; N: GlcNAc; F: Fuc)
N-glycan ID Glycan Structure and MSn pathway
MS" Pathways:
983.6
*~ 690.5

Dimer Tetra
mer

445.3

N1
(H2N2)
+++

+++

+++

N/A

MS4
445

MS" Pathways:
1 1 5 7 — • 690

445

N2-A
(H2N2F)

MS3!
690 I

MS" Pathways:
1157—»-864N2-B
(H2N2F)

676

472

MS3
864

MS4
676

N/A

6'
MS" Pathways:
1157—»~864-

N2-C
(H2N2F)

646-

458

MS3
864
MS4
676
N/A
MS4
646
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MS" Pathways:
1187—*~894~

649—*-431

MS5 MS4
431 649

N3
(H3N2)

MS" Pathways:
1361 — ^ 8 9 4

676

+++

+++

+++

+++

+++

+++

431

MS4
676

N4-A
(H3N2F)
MS4
676

MS3
894

MS" Pathways:
1361—»1068-

-880—

MS6
431

676

MS3
1068

N4-B
(FH3N2)
MS4
880

MS" Pathways:
1391—»~1098
N5
(H4N2)

-»-880—*-635
MS3
098

QMS4
880
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MS" Pathways:
1565—»-1098

-•880

MS4
880
N6
(H4N2F)

+++

N/A

+++

+++

+++

+++

+++

N/A

MS3
1098
MSn Pathways:
1595—^1302MS4
880

N7-A
(H5N2)

MS4
880
MS" Pathways:
1595
*- 1302
N7-B
(H5N2)

MS3
1302
•• 1084

866

*• 648

MS4
1084

MS5
866

MS6
648

MS" Pathways:
1606—^1139N8
FH3N3

880

MS3
1302
880

676

431

MS6 MS3
431 1139
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Putative structure, no MS" analysis due to
weak signals
N9
H6N2
+++

+++

N/A

+++

Putative structure, no MS" analysis due to
weak signals
N10
H7N2

Putative structure, no MS" analysis due to
weak signals

N11
H8N2
N/A

N/A: Not applicable for this form. +++: major component; +: minor
component.
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Figure 3.11. MALDI-MS profiles of A/-glycans were released from the
stalk region tryptic peptide. Native glycans from dimer of NA (A) and
tetramer of NA (B). The fucosylated peak m/z 1079.4 is almost invisible in
the tetramer of NA. All peaks are single sodiated adducts.

Incorporation of 3H-Fuc onto Dimer and Tetramer NA in Vitro
Human fucosyltransferase 8 (FUT8) [lhara 2007], can add fucose onto
the C-6 position of the reducing end GlcNAc. It was chosen to incorporate
3

H-fucose onto dimer and tetramer NA in vitro. The reaction yield was

measured by filter binding assay as described in the experimental section.
The tetramer NA incorporated almost 4 times more fucose than the dimer
(Figure 3.12), and assayed for enzyme release activity that the tetramer NA
still maintains its sialic acid release ability (Figure 3.13). The Addition of extra
fucose onto core GlcNAc seems to neither affect the tetrameric structure, nor
lead the tetramer to de-oligomerize.
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Figure 3.12. 3 H-Fuc was incorporated onto dimer and tetramer NA by
FUT8 enzyme in vitro. The radioactivity was measured by filter binding
assay. D: dimer, T: tetramer, FUT8: human fucosyltransferase 8.
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Figure 3.13. The tetramer NA enzyme activity after fucosylated with
FUT8. No enzyme activity change was observed after the tetramer NA was
added extra core fucose by FUT8.

3.5 Discussion
Fucosvlation Seems the Key Difference between Dimer and Tetramer
The glycoprotein NA of 1918 influenza viruses (H1N1) exists in
monomeric, dimeric, and tetrameric forms, but only the tetramer
demonstrates the enzyme activity (the ability to release sialic acid residue
from glycoconjugates). Previous report has showed that A/-glycosylation
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pattern was the only difference between tetramer and dimer/monomer [Wu
2009]. In order to seek the structural features which are responsible for the
formation of the tetramer NA, A/-glycans from both dimer and tetramer NAs
were enzymatically released and characterized by MSn.
As expected, recombinant NA expressed simple pauci-mannose type
and high mannose type A/-linked glycans (Table 3.3) because inset cells do
not carry the enzymes required for more complex type glycans [Kost 2005].
However, the distinct difference between dimer and tetramer is the features
of activity and a differential measure of fucosylated glycans. Dimer and
tetramer share one fucosylated composition, FucMan3GlcNAc2 (63.9% in
dimer vs. 18.1% in tetramer). This is the only fucosylated composition found
in the tetramer. Other three fucosylated compositions, FucMan2GlcNAc2,
FucMan4GlcNAc2, and FucMan3GlcNAc3, were also found in the dimer, but
not in the tetramer. Fucosylated glycans accounts for 73.6% of the total in the
dimer, but only 18.1% in the tetramer (Table 3.2). Detail characterization via
MSn showed that the majority of fucosylated structures occurred on the
6-position of the reducing end GlcNAc, although the trace amounts were
found on the outer antennae of mannose such as N4-B (Table 3.3). For the
compositions shared by both dimer and tetramer forms, no structural
difference was found. Even there were two large high-mannose type glycans
(H7N2 and H8N2) in tetramer, absent in dimer, but both of them only consists
less than 1.5% in total (Table 3.2). Thus it appeared that excess fucosylation,
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especially 6-Fuc modification on the reducing GlcNAc, was the key difference
between tetramer and dimer.
Fucosylation Fails to Alter Tetramer Enzyme Activity
Fucose can be enzymatically (FUT8) added in vitro to the core GlcNAc
of the dimer and tetramer NAs. The tetramer when compared to the dimer
can accept almost four times more fucose when measured by a filter binding
assay (Figure 3.12). This was in agreement with the mass spectrometry
results which indicated that fucosylated glycans were 73.6% in the dimer but
only 18.1% in the tetramer (Table 3.2). To our surprise, the tetramer NA
retains its enzyme activity after the incorporation of excess fucosylation,
suggesting that the A/-glycans were not directly involved in the receptor
binding or influence the tetrameric three-dimensional structure once they are
formed. It does seem that A/-glycans play a key role in the oligomerization
process to regulate the formation of the active tetrameric shape before it
reaches the cell surface, but has no influence once formed.
Fucosylation in the Stalk Region
Active tetrameric NA consists of a thin stalk region and a large
globular binding head. The interaction among the four identical monomers in
the stalk region is essential to retain active tetrameric structure [Xu, 2008]. It
is currently not know whether the glycans in stalk area contribute directly to
that configuration but given the compact shape of the stalk, the glycans in this
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area may affect the correct folding of NA subunits prior to the formation of the
active NA. Five potential A/-glycosylation sites (Asn50, 58, 63, 68 and 88)
occur in the stalk region, when isolated and profiled for A/-glycosylation only a
trace amount of the fucosylated structure (FucMan3GlcNAc2, m/z 1079.4)
was detected in the tetramer NA which was in contrast to the dimer (Figure
3.11a and 3.11b). Since the stalk region contained four glycosylation sites
(Asn50, 58, 63, and 68), it can be suspected that the trace amount of
fucosylation may come from the site Asn88. Core fucosylation may have a
definitive effect on the correct folding of each subunit due to its proximity to
the protein backbone, comparing to other sugar residues. The four
A/-glycosylation sites in the stalk region are shared by all known avian N1
type viruses, and most human H1N1 type viruses [Xu 2008; Reid 2000],
implicating its significance to the structural formation. Unlike HA, which
acquired up to seven extra glycosylation sites for human viruses under
selective pressure, human H1N1 NA doesn't acquire any extra glycosylation
site in the stalk region, and only sporadic cases reported with one or two
additional site in the globular head [Reid 2004]. Thus, it may suggest that
A/-glycans in the stalk region is essential of the tetramer NA formation, and
extra glycosylation site may inhibit the formation of that structure, even if it
may benefit the virus t o escape the host antibody neutralization.
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Fucosylation is Ubiquitous in Human Cells
Although human cells produce more complex-type A/-glycans rather
than simple high-mannose type glycans, the fucosylation is ubiquitous in the
human cells [Ma 2006]. Core fucosylation may carry the same property of
inhibiting the tetramer formation in human cells regardless of the extensive
modification on the antennae. Fucosylation has been reported to take part in
many important biological functions, such as: blood transfusion reactions,
selectin-mediated leukocyte-endothelial adhesion, host-microbe interactions,
and numerous ontogenic events [Ma 2006]. Alternations in the expression of
fucosyltransferase activity have also been observed in many pathological
processes, such liver disease, and cancer developing, etc [Mehta 2008;
Comunale 2009; Miyoshi 2008; Imre 2008; Shah 2008]. Thus we suggest
another example where fucosylation may control the formation of influenza
virus NA. This is the first report to characterize the structural details of
A/-glycosylation of the viral NA. With this assumption, it exposes an
alternative mechanism for the host system to regulate the influenza virus
infection which has never been reported previously. Most importantly, this
result may bring to focus a new anti-virus strategy for consideration.

Fucosylation may Explain the High Death Rate in Young Adults
It has been reported that NA was one of three factors critical to its
highly pathogenic nature of the 1918 virus [Pappas 2008]. Given the severity
of that pandemic, it is reasonable to speculate that thel 918 viruses can grow
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efficiently in human respiratory cells. An intriguing nature of the 1918 viruses
was its higher death rate among the young adult age group 25-40. This can
not be explained by common immunological considerations. Hence, it may be
the case less fucosylation enzyme in this age group 25-40 makes them more
susceptible to virus infection due to the production of more tetrameric NA.
However, there is no direct evidence to correlate fucosylation activity to
various age groups at the present, especially those enzymes in the
respiratory epithelial cells. This is only a hypothesis.
Summary
In this chapter, a glycosylation difference between the active NA
(tetramer) and the inactive NA (dimer) of the 1918 influenza virus has been
identified. It appears that fucosylation on A/-glycans, especially those located
on the stalk region, prevents oligomer formation to the active NA tetramer.
Since addition of fucose onto the innermost GlcNAc of A/-glycans in tetramer
did not affect tetramer's enzyme activity, it may suggest that this kind of
regulation is occurred in the early stages of glycoprotein biosynthetic
pathway. Moreover, this is the first report to characterize A/-glycan structures
of the NA from influenza A virus, which will hopefully expand our
understanding to this notorious virus, and help us to prepare for future
pandemics.

101

CHAPTER 4
Sial-Gal Linkage Analysis of the Human
Receptor of Influenza Virus

4.1 Introduction
Influenza Virus Receptor
Avian influenza, a highly contagious virus, has been able to cross
species barriers and infect a broad range of mammals including human, pig,
horse, tiger, whale, etc (Table 3.1 in Chapter 3). As discussed in Chapter 3,
the major surface glycoprotein haemagglutinin (HA) is the molecule that
recognizes the host receptor and initialize viral entry into the host cell [Weis
1988]. A terminal disaccharide moiety sialic acid-galactose (Sial-Gal) either
from glycoprotein or glycolipid on the host cell surface is the receptor for HA
attachment. It has been long believed that avian influenza viruses prefer
binding to a Sialtf (2,3)Gal moiety, whereas the human viruses favors binding
to Sial ar(2,6)Gal epitope [Pekosz 2009; Russell 2008;Shinya 2006; Debby
2006]. Because of this recognition barrier, avian influenza will not infect
humans directly, and vice versa, human viruses do not transmit to avian
species. Pigs were traditionally considered as "the mixing vessels" to
produce recombinant viruses, which are able to infect both human and avian
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species as pigs have both a {2,3) and a {2,6) Sial-Gal linkages in their
respiratory tracts [Gambaryan 2005; Ha 2001; Kida 1988].
Recently direct avian-to-human infections have been reported on
several subtype viruses: such as H5N1 [Webster 2005; Guan 2004], H7N7
[Fouchier 2004], H9N2 [Wan 2007], associated with the enhanced
pathogenicity. The emergence of these highly pathogenic viruses increases
the likelihood of future influenza pandemics. Most importantly, these direct
avian-to-human infection cases are controversial in light of the previous
proposal of HA binding specificity. Thus, the presence of Sialar(2,3)Gal
moiety in the human respiratory tract is the key issue and needs to be
addressed indefinitely.
It will be necessary to understand the basic human anatomical
distribution of respiratory tract tissues and organs before considering
mechanism of influenza virus infection. Generally the human respiratory
system can be divided into an upper and a lower respiratory tract (Figure 4.1).
The upper tract includes the nasal passages, pharynx and the larynx, while
the lower comprises trachea, bronchi and lungs (Figure 4.1).
Previously, Sialcr (2,3)Gal epitope has been detected in the human
lower tract but not the upper by using classical lectin methods (Figure 4.2)
[Shinya 2006]. The detection of Sialor(2,3)Gal is almost invisible in the upper
tract, which were dominated by Sialor(2,6)Gal moiety (Figure 4.2, a-c). In
contrast, Sialar(2,3)Gal is present sporadically in bronchiole tissues, and has
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significant amounts in alveolus tissues of the lower respiratory tract (red color,
Figure 4.2, d-e). From these results, it was proposed that avian virus such as
H5N1 can infect and replicate efficiently in the human lower respiratory tract if
the virus get the opportunity to enter the lower respiratory tract (such as farm
workers who may have direct and repeat contact to sick poultry). The paucity
of Sialar(2,3)Gal epitope in the human upper respiratory tract may prevent
readily human-to-human transmission of avian viruses, which are not usually
able to reach the lower tract. Moreover, avian H5N1 virus was also reported
to infect human type 2 pneumocytes and alveolar macrophages, two primary
cells from the human lower respiratory tract [Riel 2006].
Human respiratory tract
Upper respiratory tract
Nasal cavity
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Pharynx
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Figure 4.1. The anatomical distribution of human respiratory tract.
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Figure 4.2. Reactivity of human respiratory tissues with lectins specific
for different sialic acid linkages [Adapted from Shinya 2006]. (a) Nasal
mucosa; (b) paranasla sinuses; (c) bronchus; (d) bronchiole; (e) alveolus.
Res: respiratory bronchiole (adjacent to alveoli); Ter, terminal bronchiole
(distal to alveoli); Alv, Alveolus. Green colors, reaction with sambucus nigra
lectin, indicate the presence of Siala (2,6)Gal. Red colors, reaction with
Maackia amurensis lectin, indicate the presence of Siala(2,3)Gal.
In contrast to the above conclusions, Nicholls etal. has found that the
human nasopharyngeal, adenoid and tonsillar tissues (cultured ex vivo) can
be infected with avian H5N1 viruses regardless of the paucity of Sialar
(2,3)Gal in these tissues [Nicholls 2007a]. In addition the viral yield was
increasing with the incubation time, indicating an effective infection and
replication. This was further supported from a report that H5N1 virus has
been detected in trachea epithelial cells of a human patient [Gu 2007]. These
results strongly suggested that avian influenza virus receptors must be
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present in the human upper respiratory tract. These opposing data to this
most important question prompted us to apply mass spectrometry-based
method to clarify this issue avoiding the biological constraints inherent with
lectins.
Common Lectin Histochemistry Methodology
Lectins are a class of naturally occurred proteins which are
characterized by their properties to bind specific carbohydrate residues. They
have been widely used in various biological researches due to their affinities
to specific carbohydrate epitopes. In fact, Haemagglutinin (HA) of influenza
virus is also a type of lectin, which binds to the sialic acid galactose residue
on the host cell surface. Usually lectins are conjugated with fluorescent
groups to facilitate detection. There are two types of lectins commercially
available to investigate Sial-Gal linkage: sambucus nigra agglutinin (SNA) for
Sialor(2,6)Gal and maacka amurensis agglutinin (MAA) for Sialor(2,3)Gal.
The later exists in two different isoforms, MAA1 and MAA2 [Nicholls 2007a;
Nicholls 2007b]. It was reported that MAA2 is more specific toward Sialor
(2,3)Galyfl (1,3)GalNAc moiety, and MAA1 is more specific to Sialor(2,3)Gal/?
(1,4)GlcNAc residue [Konami 1994]. Since MAA1 lectin has been reported to
bind to non-sialic acid components, it has not been used as widely as MAA2
[Nicholls 2007b].
Nicholls etal. recently investigated the Sial-Gal linkages of the human
respiratory tract using these lectins and tried to determinate the accuracy of
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them, and even compared their binding specificities supplied by different
vendors [Nicollas 2007b]. The key purpose was to evaluate the lectins
accuracy and reliability. Their results are summarized as below:
•

MMA1 have widespread binding areas in both upper and lower
respiratory tracts, and more binding affinity to the cells from children
than those from adult.

•

MMA2 binding was mainly restricted to the lower respiratory tract,
such as alveolar cells, which would be comparable to Shinya etal.
result (Figure 4.2).

•

SNA binding was observed throughout the overall respiratory tract,
and stronger signals to children cells and tissues, compared to
adults.

•

MMA2 lectins from three different vendors: Roche, EY labs, and
Vector labs, showed different binding specificities.

MMA1 binding was observed in the upper respiratory tract, suggesting the
presence of Sialor(2,3)Gal. However, MMA1 was able to bind to non-sialic
acid residues, thus this result was not definite and reliable. SNA binding was
found in the whole respiratory tract, indicating the wide spread of Sialar
(2,6)Gal moiety, in agreement with current human HA binding specificity.
MMA2 lectins have distinct binding patterns among different suppliers,
indicating the results from the commercial lectins were not reliable. Most
importantly, these findings strongly suggest that common lectins were neither
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accurate nor reliable to detect the Sialor(2,3)Gal moiety in the human
respiratory tract. Moreover, current glycoarray results also found that MMA
lectin can't recognize all sialic acid galactose analogs, which are bound by
avian H5N1 virus [Steven 2006b]. This suggests even though both of HA and
MMA are the same kind of lectin, their specificity may vary, also depending
on other factors [Gambaryan 2005b]. An alternative and more-reliable
method to determinate Sial-Gal linkage is sorely needed. And mass
spectrometry is the key instrument in glycoproteomic field, and more
important the results from mass spectrometry are definitive without any
biological constraints.
Mass Spectrometrv-Based Strategies
Since sialic acid is a terminal antennal modification, the common
method would be to employ a specific exoglycosidase (called
sialidase/neuraminidase) to digest the free glycans, and measure the mass
difference before and after enzyme digestion. This method has been widely
used to determinate other monosaccharides, such as galactose, man nose
etc. Two problems are encountered when identifying Sial-Gal linkage. First,
no highly-specific commercial sialidase, that can differentiate or (2,3) or a(2,6)
linkages, is available. Currently a (2,3) neuraminidase from streptococcus
pneumoniae (Sigma catalog # N7271; Sigma, St. Louis, MO) can hydrolyze a
(2,6) linkage but with a relative lower reaction rate. Secondly, glycans with
sialic acid are not easily ionized under positive ion mass spectrometry due to
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the negative charge of the sialic acid. Also fragmentations have been
reported for native sialic acid glycans using MALDI instrument [Harvey 1999].
A second mass spectrometry-based strategy has been employed
using MSn spectral comparison of known standards [Ashline 2005]. This was
successfully demonstrated to characterize unusual modifications on the
innermost GlcNAc on C. elegan glycans [Hanneman 2006]. As for Sial-Gal
disaccharide residue, it is difficult to obtain this moiety intact due to the
extremely labile nature of sialic acid glycosidic bond. However, the loss of the
terminal sialic acid will expose either 3- or 6-position hydroxyl group on the
penultimate galactose depending on the specific linkage. This fragment ion
will have a unique spectrum. This method has been successfully applied to
determine the linkage in a recombinant IgG Fc A/-glycans [Anthony 2008].
The reason for this research was that 100% of the anti-inflammatory function
of IgG was completely dependent on one specific A/-glycan sialylation
structure. As shown in the Figure 4.3, the Sial-Gal linkage from IgG Fc glycan
was shown to be a #(2,6) linkage since in the product hydroxyl galactose
spectrum was closer to that obtained from the 2,6-sialyllactose standard
[Anthony 2008].
Another mass spectrometry strategy was published recently for
Sial-Gal linkage determination using a chemical cyclization method [Wheeler
2009]. Traditionally stabilization of sialic acid was obtained by selectively
methylation of the carboxyl group with methyl iodide, to form the
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corresponding methyl ester. This enables the detection of sialic acid glycans
in MALDI spectra [Powell 1996]. The new strategy, the sialylo-glycans were
esterificated in methanol with 4-(4,6-dimethoxyl-1,3,5-triazin-2-yl)-4-methyl
-morpholinium chloride (DMTMM). The intriguing feature of this method was
not only stabilization of sialic acid, but also differentiation of Sial-Gal linkage
directly since a (2,6) linkage will form a methyl -ester, and a (2,3) linkage will
produce a six-member ring lactone between sialic acid and the penultimate
galactose. The mass difference between one methyl-ester and one lactone
unit is 32 Da, allowing the mass differentiation in a MS profile. This method
has been tested successfully on the well-characterized glycoprotein bovine
fetuin, which carries both Sialor(2,3)Gal and Sialar(2,6)Gal linkages (Figure
4.40. When reacted with methyl iodide, all carboxyl groups were converted to
methyl ester, and only one single peak was present for each composition.
However, when reacted with DMTMM, multiple peaks were observed for
each composition due to the mass difference for Sial-Gal a (2,3) and a (2,6)
linkages (Figure 4.4).
Due to the significance of Sial-Gal linkage determination on influenza
virus infection, both MSn spectral comparison and DMTMM/MeOH cyclization
methods have been applied to identify the exact Sial-Gal linkage on the
human respiratory tract. In this project, two model cell lines were chosen:
Detroit 562 and A549, (obtained from ATCC), as representation of the human
upper and lower respiratory tract, respectively.
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4.2 Experimental Procedures

Materials and Reagents
Human pharynx epithelial cell lines (Detroit 562) and Type II alveolar
bronchial epithelial cell line (A549) were purchased from American Type
Culture Collection (ATCC) Inc. (Manassa, VA 20108). The glycerol-free
PNGase F and associated reagents (10 x denaturing buffer, NP-40, G7
buffer) were purchased from New England Biolabs (Beverly, MA). Proteomic
grade trypsin (25 \ig per vial), dimethyl sulfoxide, sodium hydroxide,
iodomethane, sodium borohydride, dithiothreitol, urea, iodoacetamide,
trifluoroacetic acid, tetrahydrofuran, 2,5-dihydroxybenzoic acid (DHB),
toluene and ethanol were obtained from Sigma-Aldrich (St. Louis, MO).
Membrane dialysis cassette (7000 MWCO) was purchased from Pierce
(Prod# 66370, Rockfold, IL).
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Figure 4.3: One Strategy for determining Sial-Gal linkage. (A) The IgG Fc
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acid). (B) Sequential mass spectrometry (MSn) analysis of SNA-enriched
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2,6-sialyllactose (D) [Anthony 2008].
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(2,3) and «(2,6) linkages were demonstrated by the multiple peaks for a
single glycan in (b) [Wheeler 2009].

Total Protein Extraction
Both cell lines were cultured according to the provider's
recommendation (www.atcc.org). The cells were harvested and suspended in
100 ml_ of an ice-cold lysis buffer. The lysis buffer (1L NP-40) was combined
with 30 ml_ of 5M NaCI, 100 ml_ of 10% NP-40, 50 mL of 1M Tris (PH 8.0),
and 820 mL of water. The lysis buffer was shaken occasionally while
standing in an ice-bath for 30 minutes. The nuclei and cellular debris were
removed by low-speed centrifuge (1000 rpm for 5 minutes). The pellet was
discarded and the supernatant was kept for the subsequent analysis.
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Synthesis of DMTMM
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
(DMTMM) was prepared from N-methylmorpholine (NMM, Sigma) and
4-chloro-2,6-dimethoxytriazine (CDMT, Lancaster) in anhydrous
tetrahydrofuran [Kunishima 1999]. Briefly, 101 mg NMM (1 mmol) and 193
mg CDMT (1.1 mmol) was dissolved in 3mL THF at r.t. The reaction was
stirred for 30 minutes. Then the solution was washed by 0.5 ml_ THF several
times and centrifuged to discard the supernatant. The crude product was
dried under vacuum stored in -20°C for the following reaction without further
purification.
M-qlvcan Release by PNGase F
The total proteins extracted from both cell lines were dialyzed against
5 mM NH4HCO3/0.01% SDS overnight (7000 MWCO) to remove low
molecular salts and impurities. The proteins were recovered, dried and stored
in -20 °C for future use. Dried protein sample (around 1 mg) was dissolved in
a protein denaturing buffer, and the A/-glycans were released following the
same procedure as described in Chapter 2.

Reductive O-qlvcan Release
The total protein (1 mg each) was dissolved in 50 mM NaOH/1 M
NaBH4 solution and incubated at 50 °C for 16 hours. The reaction was
terminated via the addition of 1 ml_ acetic acid in an ice bath. Three ML of
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ethanol was added into the solution, and the solvents removed by
evaporation in a speed-vac. Volatile methyl borates were removed by repeat
evaporations with 1 ml_ of 1% acetic acid in methanol under a stream of
nitrogen gas.
Glvcan Purification and Permethvlation
Released glycans were separated from the proteins by a Sep-Pak
C18 SPE cartridge (Waters). The glycans were further desalted and purified
using a hand-packed graphitized carbon cartridge (Alltech) into neutral (25%
acetonitrile fraction) and acidic (30% acetonitrile containing 0.1%
trifluoroacetic acid) fractions. The dried glycan sample was dissolved in 300
|j,L DMSO in a glass tube, followed by the addition of a small amount ground
NaOH powder and vortexing for 5 mins. lodomethane (50 |iL) was then
introduced into the tube, followed by vortexing extra 40-50 mins, to form a
white cloudy suspension solution. The reaction was stopped by the
sequential addition of 1 ml_ dichloromethane and 1 ml_ of 5% acetic acid in
ice bath. The methylated glycans were isolated by liquid-liquid (CH2CI2/H2O)
extraction, repeated 3 times. The combined organic layers were then washed
5-6 times with water. The dichloromethane was evaporated under N2 gas and
ready for mass spectrometry analysis.
Glycans Modified with DMTMM/MeOH
Purified acidic A/-glycans (from 500 u.g protein) were dissolved in 100
u.L MeOH with a small amount of DMTMM (-20 mg). The reaction solution
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was incubated at 80 °C for 90 minutes. The methanol was removed under a
stream of nitrogen gas, and the mixture was re-dissolved in 50 u.L H 2 0.10 uL
chloroform was added repeatedly (three times) to extract the excess
reagents. The product was further purified by a hand-made graphitized
carbon column (30% acetonitrile containing 0.1%TFA fraction). The solvent
was removed and stored in -20°C for mass spectrometry analysis.
Mass Spectrometry
Native glycan MS profiles were performed on a MALDI-TOF
instrument (MALDI-CFR, Shimadazu, Kyoto, Japan). One ut_ matrix solution
(10 mg DHB in 1 ml_ of 50% acetonitrile solution containing 0.1% TFA) was
applied on MALDI plate and air dried. Then 1 u.L sample solution was applied
to the well and mixed evenly with the matrix on the plate. When the solution
was dry, a drop of pure ethanol was applied onto the well and the sample and
matrix re-crystallized. MSn analyses were performed on the permethylated
reduced glycans (ESI-LTQ, Thermo, Waltham, MA).

4.3 Results

Sialvlated Standard Carbohydrates Tested with DMTMM
To fully evaluate this method, two standard sialylated trisaccharides
(2,3 sialyllactose and 2,6 sialyllactose) were tested with DMTMM reagent
(Figure 4.5B). Only one major product peak (methyl-ester: m/z 670.2) was
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observed from 2,6 sialyllactose, and no starting material remained. It
indicated quantitative conversion of 2,6 linkage to the corresponding
methyl-ester product (Scheme 4.1). In contrast, most of 2,3 sialyllactose was
converted to the expected lactone product (m/z 638.2, Figure 4.5A), which is
32 Da less than the methyl ester product. However, two small peaks,
corresponding to the starting material and the methyl ester were also found
(m/z 656.1 and 670.2, respectively, Figure 4.5A) in the spectrum. Although
this result may suggest Sial-Gal #(2,3) linkage may not be able to covert to
the lactone quantitatively which was in agreement with the recent report
[Wheeler 2009], the major purpose for this project is only to qualitatively
detect the presence of 2,3 linkage.
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Figure 4.5. Positive MALDI-TOF mass spectra of two standards; 2,3
sialyl-lactose (A) and 2,6 sialyl-lactose (B) after derivatization with
methanol/DMTMM. The 2,6 linkage formed the methyl-ester product
quantitatively, no starting material and other products were observed. The
major product of «2,3 linked sialic acid standard was the lactone, whereas
some starting material (S.M.) and methyl-ester products were observed. All
ions contain one sodium atom.

AZ-Glvcans from Bovine Fetuin Reacted with DMTMM
Further verification of this method was carried out on the A/-glycans
from bovine fetuin which possessed both sialic acid linkages, and also
reported by Wheeler (Figure 4.4). Free and purified fetuin A/-glycans were
modified with DMTMM in methanol. The result is shown in Figure 4.6, which
is similar to Figure 4.4B. The abundant composition was tri-antennary
A/-glycans with two major peaks (m/z2879.5 and 2911.3), corresponding to
the Sial-Gal combination of (2,3)2 (2,6) and (2,3)(2,6)2, respectively (Figure
118

4.6). The second composition was the tri-antennary A/-glycan with four sialic
acids groups. Two major combinations of this composition were the
(2,3)2(2,6)2 and (2,3)(2,6)3 (m/z3184.4 and 3216.4), respectively. The single
sialic acid composition is almost invisible (Figure 4.6), which was evident in
Figure 4.4. This slight difference may come from the glycosylation pattern
change among different samples. Most interesting, this result successfully
demonstrates that this method is useful to differentiate Sial-Gal linkages,
especially for those containing multiple sialic acid residues. In addition, no
significant un-reacted material was found in this spectrum.
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Figure 4.6. Positive MALDI-TOF mass spectrum was obtained on
M-glycans from bovine fetuin after derivatization with methanol/DMTMM.
The presence of separate peaks correspond to one composition demonstrate
the potential use of this method. The combination of «(2,3) and a(2,6)
linkages of each single peak was depicted as above. All the ions contain one
sodium atom.

Verification of Sialic Acid in A/-Glycans of A549 and Detroit 562 Cell
Lines
Both A549 and Detroit 562 cell lines have never been studied relative
to their glycosylation pattern. The presence of sialic acid was first verified
prior to investigate the Sial-Gal linkage types. A/-glycans were enzymatically

120

released from both cell lines and separated into neutral and acidic fractions
using a PGC cartridge. Permethylation was carried out in order to remove
sialic acid negative charge effect under positive ion MALDI-MS. Both cell
lines express a series of complex-type A/-glycans containing multiple sialic
acid residues (Figure 4.7). In Detroit 562 cell line (Figure 4.7A), the major
component was tri-antennary glycan (m/z 3602.8) with three sialic acids.
Some other peaks (m/z 3963.9, 3357.7, 3241.7, 2966.4, 2792.4, and 2605.3)
were observed containing one to four sialic acids as determined by their
mass compositions. In A549 cell lines, the abundant acidic peak was also the
tri-antennary glycan (m/z 3602.8) with three sialic acid residues. But the
second abundant peak was a di-antennary acidic glycan (m/z 2792.4), which
was only a minor component in Detroit 562 cell lines. Some other low
abundant acidic glycans (m/z 2185.0, 2430.8, 2605.3, 2880.4, 3037.5,
3241.7, 3357.7 and 3963.9) were also detected as annotated (Figure 4.7B).
From the above data, it was clear that both of cell lines consist of many
sialylated glycans, which was in agreement with the fact that both cell lines
have been used clinically to culture influenza viruses. The cartoons of each
peak in the spectra simply represent the most plausible topology according to
the biological synthetic pathway, and have not been fully characterized by
MSn analysis.
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Figure 4.7. Positive MALDI-TOF mass spectra of M-glycans from Detroit
562 cell line (A) and A549 Cell line (B) after permethylation. The cartoons
represent the most plausible topology for each peak according to the
biological synthetic passway. The detailed structures have not been
characterized by MSn techniques. All the ions contain one sodium atom.
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Both a(2,3) and or(2,6) linkages Detected in Detroit 562 Cell Lines
Detroit 562 cell lines were isolated from human pharynx epithelial cells.
The presence of Sialor(2,3)Gal residue was an important question to
evaluate the likelihood of avian influenza virus spreading in human. Thus, the
acidic A/-glycans from Detroit 562 cell lines were reacted with DMTMM/MeOH
and MALDI-MS was obtained (Figure 4.8). Although the abundant peak (m/z
2114.7) represented a single sialic acid glycan with a(2,6) linkage, significant
portions of a(2,3) linkages were also found, especially for those large multiply
sialylated glycans, m/z 2879.9, 2912.0, 3185.2, and 3217.2, (Figure 4.8).
Since Sialar(2,6)Gal will not be able to form the lactone product, the unique
m/z of each peak indicate the presence of Sial«r(2,3)Gal epitope
unambiguously in Detroit 562 cell line.
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Sialic Acid Linkage determination in A549 Cells by MS"
A549 cell line originated from the human lower respiratory tract. Both
a (2,3) and a(2,Q) linkages were expected as previously detected by the
lectin methods [Shinya 2006]. MSn disassembly was chosen to analyze the
sialic acid linkages for this model cell line. Both N- and O-glycans were
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released and permethylated. The internal galactose B ions (1,2 ene and 3/6open hydroxyl group) from two standards (2,3-sialyllactose and
2,6-sialyllactose) have distinct spectra (Figure 4.9A and 4.9B). The most
abundant peaks were fragment ions m/z 153 and 125 from 3-sialyllactose,
and the relative ratio between them was around 42% (Figure 4.9A). In
contrast, the two most abundant peaks were ions m/z 197.1 and 139 from
6-sialyllactose, and the relative ratio between them was around 70% (Figure
4.9B). Moreover there are two low abundant peaks {m/z 111.1 and 212.0) in
the spectrum, which was different from 2,3 linkage fragmentation.
The most abundant composition from acidic A/-glycans of this cell line
{m/z 3602.8, Figure 4.7B) was sequentially disassembled and the fragment
spectrum of the internal Gal B ion was shown (Figure 4.9C). The most
abundant ions m/z 153 and 125 clearly indicated the presence of or (2,3)
linkage. Since the spectrum was not similar to the standard 3-sialyllactose
spectrum (Figure 4.9A), it suggested that a mixture of both a{2,3) and a{2,6)
linkage types, but the majority should be or (2,3) linkage. The simplest
O-glycan containing one sialic acid residue (Sial-Gal-GalNAc, m/z 895.6) was
chosen to be disassembled. The spectrum was more similar to the standard
or (2,3) spectrum such as in Figure 4.9A: suggesting the presence of or (2,3)
linkage in O-glycan (Figure 4.9D). Therefore, Sialor(2,3)Gal linkage was
detected in both N- and Oglycans from A549 cell line.
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4.4 DISCUSSION

Sialic Acid Linkage Determination by PMTMM Approach
As demonstrated above, DMTMM derivatization provides a unique
way to differentiate a (2,3) and a (2,6) Sial-Gal linkages because the C-4
hydroxyl group in the galactose prefers to form a six member-ring lactone
with the carboxyl group of sialic acid in Sialor(2,3) Gal moiety (Scheme 4.1).
While, no such hydroxyl group in galactose has the same ability in Sialar(2,6)
Gal moiety to form a lactone. The only product for a (2,6) linkage is a
methyl-ester (Scheme 4.1). The mass difference between one methyl-ester
moiety and one lactone moiety is 32 Da, distinguishable by mass analysis.
Although Sialor(2,3)Gal may not be converted into the lactone quantitatively
from the standard carbohydrates, the remaining starting material was
insignificant compared to the products. Also no significant starting material
was observed in fetuin and Detroit 562 samples. Therefore, the DMTMM
approach seems the most definite and straightforward approach to determine
the presence of Sialcr (2,3)Gal linkage.
Relative Quantification of Sial-Gal Linkages
Additional information usually encountered is the relative ratio of each
linkage a (2,3) and a (2,6) in a specific glycoprotein, or cell, or organism.
Without modification of carboxylic acid group, glycans with native sialic acid
may form complex fragmentation peaks under positive ion mass
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spectrometry, and have different ionization efficiency under negative ion
mode mass spectrum due to the various carboxylic acid groups in each
individual glycan, making the calculation of relative quantification impossible.
The common methylation or permethylation methods provide the stable
signal of sialic acid under positive ion mode of mass spectrometry [Powell
1996], which enable the relative quantification of each glycan. However, the
evaluation of relative ratio of or (2,3) and or(2,6) linkage was not possible.
With this new DMTMM approach, the quantification of sialic acid linkage
seems feasible. Once Sial-Gal residue was converted into lactone or
methyl-ester, the ionization efficiency of each glycan can be assumed to be
approximately the same regardless of the number of sialic acid residues of
each glycan. It is worthy to point out that the lactone and methyl-ester may
have slight difference in the ionization efficiency, but this difference should be
small. Therefore, it provides a structural basis to approximate the relative
ratio of specific linkage of sialic acid.
Given that requirement, the first example was to evaluate the ratio of
acidic A/-glycans from bovine fetuin (Figure 4.6). Since the signal intensity in
MALDI spectra is in proportion to mole abundance [Harvey 1999], the relative
ratio of each glycan can be approximated from individual signal intensities.
As for glycans with multiple sialic acid residues, the intensities of those
glycans were multiplied with the number of each specific linkage of sialic
acids. For instance, m/z 3184.4 represents a tetra-sialic acid glycan with two
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a(2,3) residues and two a(2,6) residues (Figure 4.6). Thus, the relative
intensity of «(2,3) linkage in this peak was measured by (9.5*2 = 19). All the
peaks for acidic A/-glycans from fetuin were re-calculated and summarized in
table 4.1. The total relative intensity of a(2,3) and a{2,6) linkages is 71.8 and
118.7, respectively (Table 4.1, last row). So the relative ratio of a (2,3)
linkage in the total sialylated glycans from this glycoprotein was calculated as
37.7% {71.8/ (71.8+118.7)*100%}. Although this calculation has not been
fully tested with standard samples, it does provide a simple way to
approximate the relative quantity of sialic acid specific linkage, which is
usually challenging to obtain by other methods.
Appling this strategy, the Sial-Gal linkage ratios were calculated and
summarized for acidic A/-glycans of Detroit 562 cell line (Table 4.2). The total
relative intensity of a (2,3) linkage is 173, and 299 for total sialic acid glycans
(Table 4.2). Thus the ratio of a(2,3) linkage in the total sialic acid residues for
this cell line is 36.7% {173/(173+299)*100%}. According to this calculation,
Detroit 562 cell line has significant Sialar(2,3)Gal epitopes.
Fragment ion comparison method using MSn will not be able to
provide such information. Since permethylation is required for detail structural
analysis on complex glycans. The advantage of MSn fragment ion
comparison method will be suitable for the limited sample amount, in which
detail structural analyses is also needed.
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Table 4.1. Measuring relative ratio of Sial«r(2,3)Gal and Sialor(2,6)Gal
residues following derivatization by DMTMM of the acidic M-glycans
from bovine fetuin.
m/z

Signal

#of

#of

Relative

Relative

Intensity

(«2,3)

(a2,6)

Intensity of

Intensity of

(02,3)

(«2,6)

3216.4

8.3

1

3

8.3

24.9

3184.4

9.5

2

2

19

19

2943.3

3.5

0

3

0

10.5

2911.3

15

1

2

15

30

2879.5

10

2

1

20.0

10.0

0

5

3.7

3.7

2638.4

2.5

0

2

2606.5

3.7

1

1

2273.5

4.9

0

2

0

9.8

5.8

1

1

5.8

5.8

71.8

118.7

2241.5

£

Table 4.2. Measuring relative ratio of Sialor(2,3)Gal and Sialor(2,6)Gal
residues following derivatization by DMTMM of the acidic N-glycans
from Detroit 562 cell line.
m/z

Signal

# of (a2,3)

Intensity

#of

Relative

Relative

(02,6))

Intensity

Intensity

of (a2,3)

of (a2,6)

3217.2

13

1

3

13

39

3185.2

17

2

2

34

34

2912

21

1

2

21

42

2879.9

23

2

1

46

23

2607.1

10

1

1

10

10

2419.8

18

0

2

0

36

2387.9

23

1

1

23

23

2273.8

9

0

2

0

18

2241.8

14

1

1

14

14

2114.7

47

0

1

0

47

2082.7

12

1

0

12

0

1969.7

13

0

1

0

13

173

299

z
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Avian Influenza Virus Transmission in Human
There is no doubt about the presence of Siala (2,6)Gal residues in the
human respiratory tract. Whether the presence of Siala (2,3)Gal linkage in
the upper respiratory tract or not is questionable, which was also the main
purpose of this research project. Although common lectin method hasn't
detect any a (2,3) linkage in the human upper respiratory tract [Shinya 2006;
Nicholls 2007b], avian influenza virus can grow efficiently in the upper
respiratory tissue and primary cell lines in vitro [Nicholls 2007a]. Therefore it
does suggest that there are avian virus receptors in this area, which are in
agreement with our results using Detroit 562 cells which have significant
Siala (2,3)Gal residues, and account for 36.7% of total sialic acid residues by
the DMTMM method.
Some recent data suggests that the mechanism of viral entry in human
cells is highly complicated, and can't be simply explained by whether the
presence of proper HA receptors or not. For example, in the infection of
macrophages cells, the viruses must undergo an extra lectin-like interaction
with host mannose receptors after the initial sialic acid binding [Reading
2007]. Furthermore, some cell lines deficient of A/-glycosylation (due to a
mutation in the A/-acetylglucosaminyltransferase I gene) show viral binding to
the cell (may bind to sialic acid units of Oglycans or glycolipids of host cells),
but no viral entry. These results suggest that influenza virus may require one
or more A/-linked glycoproteins as a cofactor for cell entry after the initial sialic
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acid recognition and attachment [Nizet 2008]. Another interesting report
stated that human virus HA prefers binding to Sialcc (2,3)Gal moiety with
extended chain residues, but not avian virus, such as H5N1
[Chandraselcaran 2008]. In addition, avian influenza virus was found to
prefer 32 °C for efficient infection, and have limited infection ability at 37 °C
[Scull 2009]. Therefore, these data suggest that the poor transmission of
avian virus in human may arise from some other reasons, rather than the
absence of the Sialcc (2,3)Gal moiety.
In addition to HA binding, NA also plays a key role in the virus
infection cycle as discussed in Chapter 3. Newly formed viruses must be
released by NA from the infected host cells in order to spread to other cells
and tissues. Therefore, the establishment of a productive virus infection is
dependent on a delicate balance between both HA and NA. Unfortunately,
there are no studies regarding the balance between HA and NA for avian
influenza virus. In a word, the effective human-to-human infection of
influenza virus is a highly complex situation. The presence of proper HA
receptors may be one of the important factors, but certainly not the only
determinant.
Future Experiments
Theoretically sialic acid galactose linkage investigation should be
carried out on real human respiratory epithelial tissues like the above lectin
approach. Unfortunately, human tissues are impractical for mass
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spectrometry glycan analysis due to either the limited sample amount or strict
law regulations on human subjects. Thus, primary human respiratory
epithelial cell lines are the only choice which directed their research using
Detroit 562 and A549 cell lines. Since HA is also a kind of lectin, and many
reports have demonstrated internal residues participation in the lectin
recognition, besides of the terminal Sial-Gal moiety [Chandraselcaran 2008;
Stevens 2006b]. Therefore, a detail structural analysis of all major acidic
glycans via MSn could clarify this issue, especially those internal residues of
the antenna ending with sialic acid. This may be a key factor to evaluate viral
HA binding. For comparison, real tissues from other animals could also be
carried out to analyze the glycan structures, such as domestic chicken, duck,
pig, and the well-recognized animal model for influenza research: the ferret.
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Figure A.11. Negative ion MSn spectra to show distinguished D ion and E ion
of glycan 3 (See pp 45, 46).
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